Processing 00000000.tx.1: Insights into a plasma membrane signature SHERYL HARVEY, YAN ZHANG, FRANCE LANDRY, COLEEN MILLER and JEFFREY W. 

Phrase: "Insights into a plasma membrane signature SHERYL HARVEY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]

Phrase: "YAN ZHANG,"

Phrase: "FRANCE LANDRY,"

Phrase: "COLEEN MILLER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0402830:Miller [Professional or Occupational Group]

Phrase: "and"

Phrase: "JEFFREY W."
Processing 00000000.tx.2: SMITH Program on Cell Adhesion, Cancer Research Center, The Burnham Institute, La Jolla, California 92037  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The plasma membrane (PM) is an organized biological system that serves as a structural barrier and communication interface with the extracellular environment. 

Phrase: "SMITH Program on Cell Adhesion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "Cancer Research Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1513817:Cancer Center [Health Care Related Organization]
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]
   734   C1516225:Cancer Research [Research Activity]

Phrase: "The Burnham Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "California 92037  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The plasma membrane (PM)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "an organized biological system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0205460:biological [Qualitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "that"

Phrase: "serves as a structural barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0678594:Structural [Spatial Concept]
   760   C1706912:BARRIER [Medical Device]

Phrase: "and"

Phrase: "communication interface with the extracellular environment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1708533:Interface [Manufactured Object]
   753   C2698172:Interface [Intellectual Product]
Processing 00000000.tx.3: Many basic questions regarding the PM as a system remain unanswered. 

Phrase: "Many basic questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522634:Question [Intellectual Product]

Phrase: "regarding"

Phrase: "the PM as a system"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0596901:Membrane [Cell Component]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "remain"

Phrase: "unanswered."
Processing 00000000.tx.4: In particular, we do not understand the scope of similarity and differences in protein expression at the PM. 

Phrase: "In particular,"

Phrase: "we"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the scope of similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710028:Scope [Conceptual Entity]

Phrase: "and"

Phrase: "differences in protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "at the PM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.5: This study takes an initial step toward addressing these questions by comparing the PM proteomes of fibroblasts and mammary carcinoma cells. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "an initial step toward addressing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1261552:Step [Conceptual Entity]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]

Phrase: "these questions by comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1522634:Question [Intellectual Product]

Phrase: "the PM proteomes of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mammary carcinoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0678222:Mammary Carcinoma [Neoplastic Process]
Processing 00000000.tx.6: Three sets of proteins were revealed by the study. 

Phrase: "Three sets of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "revealed by the study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443289:Revealed [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.7: The first set comprises between 9 and 23% of all proteins at the PM and appears to be common to both fibroblasts and mammary carcinoma. 

Phrase: "The first set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "comprises between 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2700400:Comprise [Activity]

Phrase: "and"

Phrase: "23% of all proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450348:23 [Quantitative Concept]

Phrase: "at the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "common to both fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "mammary carcinoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0678222:Mammary Carcinoma [Neoplastic Process]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C0929301:Mammary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.8: A second group of proteins, comprising 40% of the proteins at the PM, is tightly linked to cell lineage. 

Phrase: "A second group of proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0441835:Group A [Classification]
   770   C0680398:secondary group [Population Group]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "comprising"

Phrase: "40% of the proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439509:/40 [Temporal Concept]

Phrase: "at the PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "tightly"

Phrase: "linked to cell lineage."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0282637:Cell Lineage [Idea or Concept]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1881379:Lineage [Conceptual Entity]
   770   C1948049:Cell [Spatial Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.9: The third set of proteins is unique to each cell line and is independent of cell lineage. 

Phrase: "The third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "set of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "is"

Phrase: "unique to each cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710548:Unique [Qualitative Concept]

Phrase: "and"

Phrase: "is independent of cell lineage."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0282637:Cell Lineage [Idea or Concept]
   806   C0332291:Independent of [Functional Concept]
   760   C0007634:Cell [Cell]
   760   C0085862:Independent [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1299583:Independent [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1881379:Lineage [Conceptual Entity]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: It is reasonable to hypothesize then, that this third group of proteins is responsible for unique aspects of cell behavior. 

Phrase: "It"

Phrase: "is"

Phrase: "reasonable to"

Phrase: "hypothesize"

Phrase: "then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "that"

Phrase: "this third group of proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "responsible for unique aspects of cell behavior."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0679165:responsible behavior [Individual Behavior]
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.11: In an effort to find proteins linked to the metastatic phenotype, we identified several proteins that are uniquely expressed at the PM of the metastatic MDA-MB-435 cells. 

Phrase: "In an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "linked to the metastatic phenotype,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0036525:Metastatic to [Functional Concept]
           Metastatic
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1522484:metastatic [Quantitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "uniquely"

Phrase: "expressed at the PM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "of the metastatic MDA-MB-435 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.12: These proteins have functions ranging from cell adhesion to the regulation of translation and the control of oxidant stress. proteome; 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]

Phrase: "ranging from cell adhesion"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0007634:Cell [Cell]
   770   C0175633:Adhesion [Natural Phenomenon or Process]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "and"

Phrase: "the control of oxidant stress. proteome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0150788:Stress control [Health Care Activity]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.13: expression profiling; 

Phrase: "expression profiling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1513400:Expression Profiling [Molecular Biology Research Technique]
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: ";"
Processing 00000000.tx.14: breast cancer; 

Phrase: "breast cancer"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0006142:Breast Cancer [Neoplastic Process]
  1000   C0678222:Breast Cancer [Neoplastic Process]
   950 E C0153661:thoracic cancer [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.15: metastasis  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  AS EARLY as 1953, Nordling (19) suggested that the clinical manifestations of cancer result from the cumulative effect of multiple genetic mutations. 

Phrase: "metastasis  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES  AS EARLY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C2985635:Reference Result [Finding]
   719   C1514811:Reference [Idea or Concept]
   719   C1706462:Reference [Conceptual Entity]

Phrase: "as 1953,"

Phrase: "Nordling"

Phrase: "(19"

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the clinical manifestations of cancer result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   753   C0205319:manifestations [Functional Concept]

Phrase: "from the cumulative effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1280500:Effect [Qualitative Concept]
   861   C1511559:Cumulative [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "of multiple genetic mutations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0026882:genetic mutations [Genetic Function]
           Mutations
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   706   C0026753:Multiple Birth [Family Group]
   706   C2015861:Multiple Births [Finding]
Processing 00000000.tx.16: The multifactorial nature of tumor progression precludes its explanation by any single factor or even a small group of factors. 

Phrase: "The multifactorial nature of tumor progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "precludes"

Phrase: "its explanation by any single factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "or"

Phrase: "even"

Phrase: "a small group of factors."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0679993:small group [Group Attribute]
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.17: It has yet to be determined how many alterations must occur to convert a normal mammary epithelial cell to carcinoma or how many additional changes are necessary for the carcinoma to progress to invasive disease. 

Phrase: "It"

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "determined"

Phrase: "how"

Phrase: "many alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "must"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "convert"

Phrase: "a normal mammary epithelial cell to carcinoma"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0014597:Epithelial cell [Cell]
   774   C0007097:Epithelial Carcinoma [Neoplastic Process]
   774   C0007634:Normal cell [Cell]
           Cell
   774   C0678222:Mammary Carcinoma [Neoplastic Process]
   774   C1268443:Normal cell [Cell]
   774   C1518174:Carcinoma Cell [Cell]
   748   C0006141:Mammary [Body Part, Organ, or Organ Component]
   748   C0221908:Epithelial [Qualitative Concept]
   748   C0929301:Mammary [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "how"

Phrase: "many additional changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "necessary for the carcinoma to"

Phrase: "progress to invasive disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205281:Invasive [Qualitative Concept]
   770   C1272688:progress [Functional Concept]
   770   C1280477:Progress [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.18: Answers to these questions require global examinations of biological systems. 

Phrase: "Answers to these questions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0508431:answer questions [Therapeutic or Preventive Procedure]
   737   C1706817:Answer [Intellectual Product]

Phrase: "require"

Phrase: "global examinations of biological systems."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031809:examinations [Health Care Activity]
Processing 00000000.tx.19: This study focuses on the plasma membrane (PM) as a system. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "focuses on the plasma membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0205234:Focus [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1285542:focus [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: "as a system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.20: The PM regulates many aspects of tumor progression including cellular differentiation, cell proliferation, adhesion and migration, pericellular proteolysis, and even the escape from immune surveillance. 

Phrase: "The PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "regulates"

Phrase: "many aspects of tumor progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1547011:Aspect [Quantitative Concept]
   726   C1879746:Aspect [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cellular differentiation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   861   C0007589:Differentiation [Cell Function]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "cell proliferation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "migration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "pericellular proteolysis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "even"

Phrase: "the escape from immune surveillance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0870509:escape [Mental Process]
   760   C1880554:ESCAPE [Event]
Processing 00000000.tx.21: Each of these events represents a point for potential therapeutic intervention, making the PM a rich source of drug targets. 

Phrase: "Each of these events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441471:Events [Event]
   770   C1457900:Each [Quantitative Concept]
   770   C3541888:Events [Classification]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a point for potential therapeutic intervention,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2924612:A point [Body Location or Region]
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "a rich source of drug targets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]
Processing 00000000.tx.22: Many of the molecules at the PM are also exposed to the extracellular milieu, providing an additional therapeutic advantage. 

Phrase: "Many of the molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0567416:molecules [Substance]
   770   C0747726:many [Conceptual Entity]

Phrase: "at the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "exposed to the extracellular milieu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0521119:Extracellular [Cell Component]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "an additional therapeutic advantage."
Processing 00000000.tx.23: As recognized more than 25 years ago by Garth Nicolson, there is a great need to define the PM as a system: "It would be convenient if these (biological) properties were definable by unique cell surface characteristics which were readily identifiable so that highly specific molecular approaches to fighting cancer could be developed" (18). 

Phrase: "As"

Phrase: "recognized"

Phrase: "more than 25 years ago"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205172:More [Functional Concept]
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]

Phrase: "by Garth Nicolson,"

Phrase: "there"

Phrase: "is"

Phrase: "a great need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027552:Need [Qualitative Concept]
   827   C0686904:need [Functional Concept]

Phrase: "define"

Phrase: "the PM as a system"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0596901:Membrane [Cell Component]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]

Phrase: ":"

Phrase: """"

Phrase: "It"

Phrase: "would"

Phrase: "be"

Phrase: "convenient"

Phrase: "if"

Phrase: "these"

Phrase: "(biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005532:Biological [Biomedical Occupation or Discipline]
  1000   C0205460:biological [Qualitative Concept]

Phrase: ")"

Phrase: "properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "were"

Phrase: "definable by unique cell surface characteristics"

Phrase: "which"

Phrase: "were"

Phrase: "readily identifiable so"

Phrase: "that highly specific molecular approaches to fighting cancer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449445:Approaches [Spatial Concept]
   744   C1292724:Approaches [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "developed"

Phrase: """"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.24: Presented with this long-recognized but unmet need, the present study was aimed at gaining some basic information on the PM proteome of mammary carcinoma. 

Phrase: "Presented with this long-recognized"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205166:Long [Qualitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "but"

Phrase: "unmet need,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "aimed at gaining"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   756   C1517378:Gain [Quantitative Concept]
   756   C1947946:Aim [Idea or Concept]
   756   C2948600:Aim [Pharmacologic Substance]
   756   C3540471:AIM [Gene or Genome]
   756   C3540472:AIM [Functional Concept]
   718 E C0205217:Increased [Quantitative Concept]
   718 E C0439661:Acquired [Temporal Concept]
   718 E C0442805:Increase [Functional Concept]
   718 E C0442808:Increasing [Functional Concept]
   718 E C1301820:Obtain [Functional Concept]
   718 E C1706701:Acquire [Activity]
   718 E C3245488:acquired [Intellectual Product]

Phrase: "some basic information on the PM proteome of mammary carcinoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1533716:Information [Idea or Concept]
Processing 00000000.tx.25: We compared the PM proteomes of mammary carcinoma to that of normal human fibroblasts. 

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the PM proteomes of mammary carcinoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to that"

Phrase: "of normal human fibroblasts."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0016030:Fibroblasts [Cell]
   827   C0086418:Human [Human]
   827   C0205307:Normal [Qualitative Concept]
   827   C0439166:% normal [Quantitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.26: Indeed, the study reveals large groups of proteins that can be considered signatures of cell lineage. 

Phrase: "Indeed,"

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "large groups of proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0679991:large group [Group Attribute]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "signatures of cell lineage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514562:Signature [Amino Acid Sequence]
   737   C1519316:Signature [Intellectual Product]
   737   C1705596:Signature [Idea or Concept]
Processing 00000000.tx.27: There are obvious and striking differences between the PM proteomes of fibroblasts and mammary carcinoma. 

Phrase: "There"

Phrase: "are"

Phrase: "obvious"

Phrase: "and"

Phrase: "striking differences between the PM proteomes of fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "mammary carcinoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0678222:Mammary Carcinoma [Neoplastic Process]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C0929301:Mammary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.28: In addition, we are able to identify a smaller set of proteins that is unique to the PM proteome of MDA-MB-435 tumor cells, a highly metastatic mammary carcinoma line. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "identify"

Phrase: "a smaller"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0547044:Smaller [Qualitative Concept]
  1000   C0700321:Smaller [Quantitative Concept]

Phrase: "set of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "unique to the PM proteome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710548:Unique [Qualitative Concept]

Phrase: "of MDA-MB-435 tumor cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   840   C0431085:Tumor cells [Cell]
   806 E C0597032:Tumor Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0027651:Tumor [Neoplastic Process]
   804   C1578706:Tumor [Intellectual Product]
   804   C3273930:Tumor [Finding]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "a highly metastatic mammary carcinoma line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0230087:Mammary line [Body Location or Region]
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.29: These proteins may represent part of the metastatic signature.  

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "part of the metastatic signature."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.30: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cells All cell lines were obtained from American Type Culture Collection (ATCC), except the MDA-MB-435 cells, which were obtained from Janet Price (University of Texas). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "All cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from American Type Culture Collection (ATCC),"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1301820:Obtained [Functional Concept]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "except the MDA-MB-435 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "were"

Phrase: "obtained from Janet Price"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0080045:Price [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(University of Texas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039711:Texas [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.31: MDA-MB-435 cells were cultured in MEM Earles (Irvine Scientific) with 10% fetal bovine serum (Irvine Scientific), 2 mM L-glutamine (GIBCO-BRL), 1 mM sodium pyruvate (Irvine Scientific), MEM vitamins (GIBCO-BRL), and nonessential amino acids (Irvine Scientific). 

Phrase: "MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in MEM Earles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(Irvine"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")"

Phrase: "with 10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(Irvine"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "2 mM L-glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "1 mM sodium pyruvate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(Irvine"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "MEM vitamins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042890:Vitamins [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "nonessential amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Irvine"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.32: All other cells were cultured according to specifications set forth by ATCC. 

Phrase: "All"

Phrase: "other cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured according to specifications"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0680240:according [Social Behavior]
   770   C2348235:Specifications [Conceptual Entity]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "forth by ATCC."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.33: Cells were grown in 15-cm dishes at 37C with 5% CO2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in 15-cm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "at 37C"

Phrase: "with 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.34: Cells were harvested at 8090% confluence. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested at 8090% confluence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.35: PM Isolation PMs were prepared using a slightly modified version of a procedure described by Chaney and Jacobson (4). 

Phrase: "PM Isolation PMs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033046:PMS [Disease or Syndrome]
   812   C1418866:PmS [Gene or Genome]
   812   C1868117:PMS [Disease or Syndrome]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a slightly modified version of a procedure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333052:Version [Functional Concept]
   748   C2607870:Version [Spatial Concept]

Phrase: "described by Chaney"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Jacobson"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.36: Briefly, cells were harvested from the culture plates with phosphate-buffered saline containing 200 M EDTA. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested from the culture plates"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0180454:culture plates [Medical Device]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1139930:plates [Medical Device]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0005971:Plate [Medical Device]
   726   C1512335:Harvest [Health Care Activity]
   726 E C3537155:Plate [Manufactured Object]

Phrase: "with phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 M EDTA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1831960:M-EDTA [Organic Chemical,Pharmacologic Substance]
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.37: The cells were suspended in coating buffer (20 mM MES, 150 mM NaCl, 400 mM sorbitol, pH 5.3) and were added dropwise through a 21-gauge needle onto a gently swirling solution of 10% cationic colloidal silica (Aldrich). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "suspended in coating buffer"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1522408:Coating [Qualitative Concept]
   770   C1553389:suspended [Idea or Concept]
   770   C1553403:suspended [Idea or Concept]
   770   C1704806:Coating [Biomedical or Dental Material]
   770   C1705537:Suspended [Functional Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20 mM MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0265215:MES [Congenital Abnormality]
   827   C1417092:MES [Gene or Genome]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "400 mM sorbitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037688:Sorbitol [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 5.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "dropwise through a 21-gauge needle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C3640175:Needle Gauge [Quantitative Concept]
   753   C0027551:Needle [Medical Device]
   753   C0456564:Gauge [Spatial Concept]
   753   C1521879:GAGE [Immunologic Factor]
   753   C1704318:Needle [Medical Device]
   753   C1882041:Needle [Spatial Concept]

Phrase: "onto a gently swirling solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "of 10% cationic colloidal silica"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0982384:colloidal silica [Biomedical or Dental Material,Inorganic Chemical,Pharmacologic Substance]
   812   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   729 E C0885771:silicas [Pharmacologic Substance]

Phrase: "(Aldrich"

Phrase: ")."
Processing 00000000.tx.38: After removal of excess silica by washing, the cells were diluted in coating buffer and were added dropwise through a 21-gauge needle onto a gently swirling solution of 10 mg/ml polyacrylic acid (Fluka). 

Phrase: "After removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of excess silica"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   777 E C0885771:silicas [Pharmacologic Substance]

Phrase: "by washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "diluted in coating buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1522408:Coating [Qualitative Concept]
   770   C1704806:Coating [Biomedical or Dental Material]
   737 E C0453946:Coat [Manufactured Object]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "dropwise through a 21-gauge needle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C3640175:Needle Gauge [Quantitative Concept]
   753   C0027551:Needle [Medical Device]
   753   C0456564:Gauge [Spatial Concept]
   753   C1521879:GAGE [Immunologic Factor]
   753   C1704318:Needle [Medical Device]
   753   C1882041:Needle [Spatial Concept]

Phrase: "onto a gently swirling solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "of 10 mg/ml polyacrylic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0054720:polyacrylic acid [Biomedical or Dental Material,Organic Chemical]
   840   C1621338:Polyacrylic acid [Biomedical or Dental Material,Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "(Fluka"

Phrase: ")."
Processing 00000000.tx.39: After washing to remove any excess of the anionic polymer, the cells were resuspended in 2.5 mM imidazole, pH 7.0, containing a protease inhibitor cocktail (Sigma) and 1 mM vanadate (Sigma). 

Phrase: "After"

Phrase: "washing to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "any excess of the anionic polymer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1979886:Excess [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in 2.5 mM imidazole,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   753   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a protease inhibitor cocktail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678420:Cocktail [Food]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "1 mM vanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042305:Vanadate [Inorganic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: After a 30-min incubation on ice, the cells were lysed by Dounce homogenization using multiple strokes with a size B pestle. 

Phrase: "After a 30-min incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed by Dounce homogenization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024348:lysed [Pathologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "multiple strokes with a size B pestle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038454:Strokes [Disease or Syndrome]
Processing 00000000.tx.41: Sheets of PM were then separated from the cellular contents by ultracentrifugation (60,000 g, 30 min) through a gradient of Nycodenz (Sigma). 

Phrase: "Sheets of PM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439643:Sheets [Spatial Concept]
   737 E C2349187:Sheet [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "separated from the cellular contents"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0007634:Cellular [Cell]
   760   C0086972:Separated [Finding]
   760   C0178539:Cellular [Functional Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0456205:Contents [Conceptual Entity]
   760   C0687118:Separated [Functional Concept]
   760   C1552853:contents [Idea or Concept]
   726 E C0423896:Content [Mental Process]

Phrase: "by ultracentrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041609:Ultracentrifugation [Laboratory Procedure]

Phrase: "(60,000 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "30 min) through a gradient of Nycodenz"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0456693:/30 min [Temporal Concept]
   778   C1442458:30 min [Temporal Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: The supernatant was aspirated, and the PM sheets, made dense by the silica and polyacrylic acid, were collected from the bottom of the tubes. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: ","

Phrase: "and"

Phrase: "the PM sheets,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0439643:Sheets [Spatial Concept]
   793 E C2349187:Sheet [Quantitative Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "dense by the silica"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "polyacrylic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0054720:polyacrylic acid [Biomedical or Dental Material,Organic Chemical]
  1000   C1621338:Polyacrylic acid [Biomedical or Dental Material,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "collected from the bottom of the tubes."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0175730:tubes [Medical Device]
   748   C1511276:Bottom [Spatial Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1547937:Tubes [Intellectual Product]
   748   C1552825:bottom [Idea or Concept]
   748   C1704474:Tubes [Quantitative Concept]
   714 E C1561954:tube [Conceptual Entity]
   714 E C1704730:TUBE [Medical Device]
Processing 00000000.tx.43: After several washes in 2.5 mM imidazole, proteins were solubilized from the membranes with 8 M urea, 2 M thiourea, 2% CHAPS, and 13 mM dithiothreitol (DTT). 

Phrase: "After several washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "in 2.5 mM imidazole,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   812   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "solubilized from the membranes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025255:Membranes [Tissue]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "with 8 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "2 M thiourea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0039958:2-Thiourea [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Thiourea

Phrase: "2% CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   827 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "13 mM dithiothreitol (DTT)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.44: Protein concentration was determined using a micro-BCA protein assay (Pierce) with bovine serum albumin as a standard. 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a micro-BCA protein assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "with bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "as a standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.45: Two-Dimensional Gel Electrophoresis Proteins associated with PMs were analyzed by two-dimensional (2D) electrophoresis. 

Phrase: "Two-Dimensional Gel Electrophoresis Proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0201719:electrophoresis proteins [Laboratory Procedure]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   722   C0678632:two-dimensional electrophoresis [Laboratory Procedure]

Phrase: "associated with PMs"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0033046:PMS [Disease or Syndrome]
   790   C1418866:PmS [Gene or Genome]
   790   C1868117:PMS [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "were"

Phrase: "analyzed by two-dimensional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1705052:2-Dimensional [Spatial Concept]
   770   C0205448:Two [Quantitative Concept]
   770   C0936012:Analyzed [Research Activity]

Phrase: "(2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: "electrophoresis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]
Processing 00000000.tx.46: Solubilized PM protein, 100 g in 200 l of 8 M urea, 2 M thiourea, 2% CHAPS, and 13 mM DTT was used to rehydrate an 11-cm immobilized pH gradient (IPG) strip (Immobiline DryStrip, 4-7L; Amersham Pharmacia Biotech). 

Phrase: "Solubilized PM protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "100 g in 200 l of 8 M urea,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0439294:g l [Quantitative Concept]
   762   C0456715:g m [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]

Phrase: "2 M thiourea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0039958:2-Thiourea [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Thiourea

Phrase: "2% CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   827 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "13 mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rehydrate"

Phrase: "an 11-cm immobilized pH gradient (IPG) strip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1441593:Gradient strip [Laboratory Procedure]
   799   C1321564:Strip [Medical Device]

Phrase: "(Immobiline DryStrip,"

Phrase: "4-7L"

Phrase: "; Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.47: The strip was rehydrated for 24 h at ambient temperature under oil. 

Phrase: "The strip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321564:Strip [Medical Device]

Phrase: "was"

Phrase: "rehydrated for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at ambient temperature"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428692:Ambient temperature [Natural Phenomenon or Process]
  1000   C0542496:Ambient temperature [Finding]
  1000   C2348236:Ambient Temperature [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1879688:Ambient [Qualitative Concept]

Phrase: "under oil."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0028908:Oil [Lipid]
  1000   C1517288:Oil [Food,Lipid]
   944 E C0996956:Olea [Plant]
   928 E C0234925:OILY [Finding]
Processing 00000000.tx.48: The proteins in the strip were focused using a Multiphor II apparatus (Amersham Pharmacia Biotech) for a total of 19,250 V-h. 

Phrase: "The proteins in the strip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "focused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focused [Spatial Concept]
  1000   C1285542:focused [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Multiphor II apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243111:apparatus [Manufactured Object]
   827   C1947951:Apparatus [Anatomical Structure]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "for a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 19,250 V-h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.49: IPG strips were subsequently equilibrated in 6 M urea, 30% (wt/vol) glycerol, 2% (wt/vol) SDS, 1% DTT, and 0.05 M TrisHCl, pH 8.8, for 15 min before the proteins were separated in the second dimension. 

Phrase: "IPG strips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1441593:Gradient strip [Laboratory Procedure]
   812   C1321564:strips [Medical Device]

Phrase: "were"

Phrase: "subsequently"

Phrase: "equilibrated in 6 M urea,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   704 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "30%"

Phrase: "(wt/vol) glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(wt/vol) SDS,"

Phrase: "1% DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.05 M TrisHCl,"

Phrase: "pH 8.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated in the second dimension."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0086972:Separated [Finding]
   760   C0205436:Second [Quantitative Concept]
   760   C0439534:Dimension [Quantitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
Processing 00000000.tx.50: Second dimension electrophoresis was performed for 15 min at 190 V and then for an additional 22 h at 65 V using a 12% acrylamide gel. 

Phrase: "Second dimension electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "was"

Phrase: "performed for 15 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at 190 V"

Phrase: "and"

Phrase: "then for an additional 22 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Additional [Functional Concept]
   753   C1883708:Then [Temporal Concept]

Phrase: "at 65 V"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 12% acrylamide gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.51: Gels were silver stained under uniform and carefully controlled conditions according to the procedure of Shevchenko et al. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "silver"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0037125:Silver [Element, Ion, or Isotope]
  1000   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1305285:Silver [Qualitative Concept]
  1000   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   916 E C0079853:Moon [Geographic Area]
   907 E C0003782:Argyria [Injury or Poisoning]
   907 E C3463959:Argyria [Eukaryote]

Phrase: "stained under uniform"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205375:Uniform [Qualitative Concept]
   790   C1608508:uniform [Quantitative Concept]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "carefully controlled conditions according to the procedure of Shevchenko et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C0012634:condition [Disease or Syndrome]
   704   C0348080:Condition [Qualitative Concept]
   704   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.52: (28). 

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.53: Silver-stained gels were scanned at 200 dpi using a Sharp JX-330 desktop scanner (Amersham Pharmacia Biotech). 

Phrase: "Silver-stained gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]
   717   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "scanned at 200 dpi"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0441633:scanned [Diagnostic Procedure]
   737 E C0034606:Scan [Diagnostic Procedure]
   737 E C2826292:SCAN [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Sharp JX-330 desktop scanner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0183115:scanner [Medical Device]
   804   C1710020:Scanner [Medical Device]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.54: Image Analysis Three to four 2D gels were prepared for each cell line. 

Phrase: "Image Analysis Three to four 2D gels"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0200765:Image analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0205449:Three [Quantitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1704254:Image [Intellectual Product]
   748   C1704922:Image [Entity]
   748   C1705052:2D [Spatial Concept]
   748   C2986796:2D [Functional Concept]
   748   C3542466:Image [Intellectual Product]
   714 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "prepared for each cell line."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007600:Cell Line [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:Line [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.55: A representative gel was chosen for image analysis, and the remaining gels were stored in 1% acetic acid and used for protein identification by mass spectrometry. 

Phrase: "A representative gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "chosen for image analysis,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0200765:Image analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C1707391:Chosen [Activity]
   770   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "the remaining gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "stored in 1% acetic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0000985:Acetic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   726   C1698986:Store [Functional Concept]
   704 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "used for protein identification"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0020792:Identification [Mental Process]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205396:Identification [Qualitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "by mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.56: Protein spots were selected using the ImageMaster Analysis software (v. 2.01, Amersham Pharmacia Biotech), and each spot was verified by the operator. 

Phrase: "Protein spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ImageMaster Analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(v. 2.01,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0445362:V 2 [Intellectual Product]

Phrase: "Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "each spot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0329155:Spot [Fish]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "was"

Phrase: "verified by the operator."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1705273:Operator [Intellectual Product]
   770   C1705274:Operator [Human]
   770   C1705275:Operator [Human]
   770   C1711411:Verified [Functional Concept]
   770   C2827501:Operator [Intellectual Product]
Processing 00000000.tx.57: The volume of each spot was quantified using the ImageMaster algorithm. 

Phrase: "The volume of each spot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ImageMaster algorithm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002045:algorithm [Intellectual Product]
   861   C1553907:algorithm [Laboratory Procedure]
Processing 00000000.tx.58: These values were summed for all spots within the gel. 

Phrase: "These values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "summed for all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1515051:Sum [Quantitative Concept]

Phrase: "spots within the gel."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0015230:spots [Disease or Syndrome]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0329155:Spot [Fish]
   770   C0848332:Spots [Sign or Symptom]
   770   C1382104:Gel [Substance]
   770   C1427618:SPOT [Gene or Genome]
   770   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.59: The percentage volume that each spot contributed to the entire gel was determined by dividing the individual spot volume by the total spot volume on the gel. 

Phrase: "The percentage volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "that"

Phrase: "each spot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0329155:Spot [Fish]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "contributed to the entire gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0439751:Entire [Quantitative Concept]
   760   C0444667:Entire [Quantitative Concept]
   760   C1382104:Gel [Substance]
   726   C1880177:Contribute [Activity]

Phrase: "was"

Phrase: "determined by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332849:dividing [Functional Concept]

Phrase: "the individual spot volume by the total spot volume"

Phrase: "on the gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.60: Based on visual inspection of the gels, spots that represented less than 0.04% of the total protein on the gel were not reproducibly detected by the software. 

Phrase: "Based on visual inspection of the gels,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C2984756:VISUAL INSPECTION [Functional Concept]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0199219:Inspection [Functional Concept]
   748   C0234621:Visual [Functional Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1382104:Gel [Substance]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "that"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "less than 0.04% of the total protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0439092:Less Than [Intellectual Product]
           less
   770   C0555903:Total protein [Laboratory Procedure]
   770   C1261360:total protein [Laboratory or Test Result]
   767 E C0439177:Protein.total [Quantitative Concept]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0547044:Less [Qualitative Concept]

Phrase: "on the gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "were"

Phrase: "not reproducibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "detected by the software."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.61: Consequently, we constrained our analysis to spots with a volume above this value. 

Phrase: "Consequently,"

Phrase: "we"

Phrase: "constrained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707494:Constrained [Conceptual Entity]

Phrase: "our analysis to spots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with a volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "above this value."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.62: When considering all eight test cell lines, we observed an average of 360  57 (mean  SD) spots with a volume above this cutoff. 

Phrase: "When"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "all eight test cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an average of 360  57"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "(mean  SD)"

Phrase: "spots with a volume"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0015230:spots [Disease or Syndrome]
   770   C0329155:Spot [Fish]
   770   C0449468:*Volume [Quantitative Concept]
   770   C0848332:Spots [Sign or Symptom]
   770   C1427618:SPOT [Gene or Genome]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C1705203:Spot [Conceptual Entity]
   770   C2700258:Volume [Laboratory Procedure]

Phrase: "above this cutoff."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442160:Cutoff [Functional Concept]
Processing 00000000.tx.63: Protein spot patterns within the gels were compared using the ImageMaster analysis software. 

Phrase: "Protein spot patterns within the gels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1317658:Protein pattern [Clinical Attribute]
   753   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ImageMaster analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.64: Gels were compared in a pairwise manner so that every cell line was compared directly to every other cell line in the study. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "compared in a pairwise manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "every cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "directly to every"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1947931:Directly [Qualitative Concept]

Phrase: "other cell line in the study."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.65: The degree of similarity between gels was determined by calculating the percentage of protein spots with an identical migration pattern. 

Phrase: "The degree of similarity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "between gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "was"

Phrase: "determined by calculating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441506:Calculating [Activity]

Phrase: "the percentage of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "spots with an identical migration pattern."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015230:spots [Disease or Syndrome]
   753   C0205280:Identical [Qualitative Concept]
   753   C0329155:Spot [Fish]
   753   C0449774:Pattern [Spatial Concept]
   753   C0600210:Migration [Social Behavior]
   753   C0848332:Spots [Sign or Symptom]
   753   C1427618:SPOT [Gene or Genome]
   753   C1533574:Migration [Physiologic Function]
   753   C1705203:Spot [Conceptual Entity]
   753   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.66: Cell Surface Iodination To track the yield of cell-surface proteins through the electrophoresis procedure, PM proteins were labeled by iodination, using procedures we have reported previously (32). 

Phrase: "Cell Surface Iodination To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0430302:Iodination [Laboratory Procedure]
   812   C0542502:Iodination [Natural Phenomenon or Process]

Phrase: "track"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "the yield of cell-surface proteins"

Phrase: "through the electrophoresis procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "PM proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "were"

Phrase: "labeled by iodination,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0430302:Iodination [Laboratory Procedure]
   790   C0542502:Iodination [Natural Phenomenon or Process]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.67: 125I-labeled cells were diluted 1:4 with unlabeled cells, and PM protein was prepared as described above. 

Phrase: "125I-labeled cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4 with unlabeled cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "PM protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "was"

Phrase: "prepared as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.68: A quantity of 100 g of PM protein containing 37,000 cpm was loaded into each of several IPG strips, and the entire 2D PAGE procedure was carried out. 

Phrase: "A quantity of 100 g of PM protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1265611:Quantity [Quantitative Concept]
   742   C1554108:Quantity [Intellectual Product]
   742   C1561573:Quantity [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "37,000 cpm"

Phrase: "was"

Phrase: "loaded into each of several IPG strips,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C1138565:pH gradient [Quantitative Concept]
   748   C1441593:Gradient strip [Laboratory Procedure]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1321564:strips [Medical Device]
   742   C1708715:Loaded [Activity]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "the entire 2D PAGE procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.69: At various points in the procedure, samples were subjected to gamma counting. 

Phrase: "At various points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "in the procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to gamma counting."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0017011:Gamma [Natural Phenomenon or Process]
   770   C1552644:Gamma [Intellectual Product]
   770   C2349976:Gamma [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C0750480:Count [Activity]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1705566:Count [Quantitative Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.70: Identification of Proteins by Mass Spectrometry The identity of several polypeptide spots was determined by peptide mass fingerprinting using methods that we have previously described (13). 

Phrase: "Identification of Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "by Mass Spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "The identity of several polypeptide spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "determined by peptide mass fingerprinting"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0030944:Peptide Fingerprinting [Laboratory Procedure]
   781 E C0016128:Peptide Fingerprint [Laboratory Procedure]
   760   C0016126:fingerprinting [Manufactured Object]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.71: Proteins were identified by comparing observed mass fingerprints to National Center for Biotechnology Information database using a Bayesian algorithm (http://prowl.rockefeller.edu/cgi-bin/ProFound). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "identified by comparing observed mass fingerprints"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0016126:Fingerprints [Manufactured Object]
   753   C0205396:Identified [Qualitative Concept]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C3152252:Mass [Quantitative Concept]
   719   C1707455:Compare [Activity]

Phrase: "to National Center for Biotechnology Information database"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0242356:Database [Intellectual Product]
   799   C0993637:Data Base [Intellectual Product]
   780   C1705803:National Center for Biotechnology Information [Organization]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bayesian algorithm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002045:algorithm [Intellectual Product]
   861   C1553907:algorithm [Laboratory Procedure]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//prowl.rockefeller.edu/cgi-bin/ProFound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439808:Profound [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.72: Five polypeptides unique to the highly metastatic cell line, MDA-MB-435, were examined by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) and mass spectrometry-mass spectrometry (MS-MS) sequencing (15, 16) by Protana (http://www.protana.com).  

Phrase: "Five polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "unique to the highly metastatic cell line,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710548:Unique [Qualitative Concept]

Phrase: "MDA-MB-435,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   827   C0026374:MDA [Geographic Area]

Phrase: "were"

Phrase: "examined by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]
   782   C2348791:Time-of-Flight [Quantitative Concept]
   739   C0023089:Laser [Manufactured Object]
   739   C0040223:Time [Temporal Concept]
   739   C0332128:Examined [Finding]
   739   C0458142:Laser [Phenomenon or Process]
   739   C0596801:Ionization [Phenomenon or Process]
   739   C1023865:Laser [Plant]
   739   C1269765:Assisted [Finding]
   739   C1555977:Flight [Intellectual Product]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706315:Laser [Medical Device]
   739   C1706515:Matrix [Body Substance]
   739   C2610507:flight [Phenomenon or Process]
   739   C3541383:Time [Temporal Concept]
   706 E C0018896:assist [Social Behavior]
   706 E C0557034:assist [Health Care Activity]

Phrase: "and"

Phrase: "mass spectrometry-mass spectrometry (MS-MS) sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1553778:Sequencing [Intellectual Product]
   804   C1561491:Sequencing [Functional Concept]
   771   C0599748:Mass Spectrometry-Mass Spectrometry [Molecular Biology Research Technique]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: "by Protana"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.protana.com"

Phrase: ")."
Processing 00000000.tx.73: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cell Lines Four breast carcinoma lines and four fibroblast lines were used to assess similarities among PM proteomes (Table 1). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Lines Four breast carcinoma lines"

Phrase: "and"

Phrase: "four fibroblast lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "similarities among PM proteomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2348205:Similarity [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.74: The analysis included the MCF7, MDA-MB-231, and MDA-MB-435 mammary carcinoma lines, all of which have been studied extensively. 

Phrase: "The analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the MCF7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596890:MCF7 [Cell]

Phrase: "MDA-MB-231,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   827   C0026374:MDA [Geographic Area]

Phrase: "and"

Phrase: "MDA-MB-435 mammary carcinoma lines,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   822   C0230087:Mammary line [Body Location or Region]
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "extensively."
Processing 00000000.tx.75: Each of these lines is also part of the NCI60, a group of cancer lines maintained for study by the National Cancer Institutes Developmental Therapeutics Program (29). 

Phrase: "Each of these lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205132:lines [Spatial Concept]
   770   C1457900:Each [Quantitative Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "also part of the NCI60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "a group of cancer lines"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0441835:a group [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "maintained for study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0557651:Study [Manufactured Object]
   790   C1314677:Maintained [Functional Concept]
   790   C2603343:Study [Research Activity]
   756 E C0024501:Maintain [Activity]

Phrase: "by the National Cancer Institutes Developmental Therapeutics Program"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   904   C1513887:National Cancer Program [Health Care Related Organization]
   861   C1522647:Developmental Therapeutics Program [Research Activity]
   803   C0033333:development program [Health Care Activity]
   799   C1709697:Program [Conceptual Entity]
   799   C2728259:Program [Pharmacologic Substance]
   799   C3484370:Program [Functional Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.76: The MDA-MB-435 cell line is especially important to the present study, because this cell line is one of the only breast carcinoma lines to exhibit extensive metastasis from the mouse mammary fat pad (25). 

Phrase: "The MDA-MB-435 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "especially important to the present study,"

Phrase: "because"

Phrase: "this cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "one of the only breast carcinoma lines to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "extensive metastasis from the mouse mammary fat pad"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0027627:Metastasis [Neoplastic Process]
   744   C2939420:metastasis [Neoplastic Process]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.77: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.78: Cell lines used for comparison of PM proteins  Analysis of PM Proteomes Although proteomic profiling has been applied to identify proteins expressed by mammary carcinoma cell lines (31) and sections of mammary tumors (2), no study has focused on the PM. 

Phrase: "Cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "used for comparison of PM proteins  Analysis of PM Proteomes"
Meta Candidates (Total=23; Excluded=5; Pruned=0; Remaining=18)
   754   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007603:Plasma membrane [Cell Component]
   753   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0025255:Membrane [Tissue]
   736   C0032105:Plasma [Body Substance]
   736   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0596901:Membrane [Cell Component]
   736   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0936012:Analysis [Research Activity]
   736   C1273517:used [Finding]
   736   C1514534:Protein Analysis [Molecular Biology Research Technique]
   736   C1524024:analysis [Functional Concept]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C1706182:Membrane [Manufactured Object]
   736   C1707455:Comparison [Activity]
   734 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734 E C1168405:protein plasma [Laboratory Procedure]
   734   C1524063:Use of [Functional Concept]
   703 E C0042153:use [Functional Concept]
   703 E C0457083:Use [Functional Concept]
   703 E C1947944:Use [Intellectual Product]

Phrase: "Although"

Phrase: "proteomic profiling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1327760:proteomic profiling [Laboratory Procedure]
   983 E C3463810:Proteomic Profile [Laboratory or Test Result]
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed by mammary carcinoma cell lines"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   866   C0596890:mammary carcinoma cell line [Cell]
   790   C0007600:Cell lines [Cell]
   790   C0678222:Mammary Carcinoma [Neoplastic Process]
   790   C1518174:Carcinoma Cell [Cell]
   767   C0230087:Mammary line [Body Location or Region]
   753   C0006141:Mammary [Body Part, Organ, or Organ Component]
   753   C0007097:Carcinoma [Neoplastic Process]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0929301:Mammary [Body Part, Organ, or Organ Component]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "sections of mammary tumors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "no study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "focused on the PM."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0205234:Focused [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1285542:focused [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.79: We reasoned that a comparison of the PM proteome between breast carcinoma and fibroblasts would provide the first information on the degree of similarity and distinction within the PM proteomes of different cell types. 

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that"

Phrase: "a comparison of the PM proteome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "between breast carcinoma"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0006142:Breast Carcinoma [Neoplastic Process]
  1000   C0678222:Breast Carcinoma [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "would"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first information on the degree of similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "distinction within the PM proteomes of different cell types."
Processing 00000000.tx.80: We isolated PMs from cells using a method established by Chaney and Jacobson (4, 10). 

Phrase: "We"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "PMs from cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0033046:PMS [Disease or Syndrome]
   790   C1418866:PmS [Gene or Genome]
   790   C1868117:PMS [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "established by Chaney"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443211:Established [Qualitative Concept]
   790   C1272684:Established [Qualitative Concept]

Phrase: "and"

Phrase: "Jacobson"

Phrase: "(4,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.81: This method enriches for PMs by first tagging the cell surface with cationic colloidal silica and then separating the PM from the remainder of the cell by a density gradient. 

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "enriches for PMs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0033046:PMS [Disease or Syndrome]
   790   C0359583:Enrich [Food]
   790   C1418866:PmS [Gene or Genome]
   790   C1868117:PMS [Disease or Syndrome]

Phrase: "by first tagging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "the cell surface with cationic colloidal silica"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0699040:Cell surface [Cell Component]
   748   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "separating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:separating [Spatial Concept]

Phrase: "the PM from the remainder of the cell"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0007603:Plasma membrane [Cell Component]
           Cell Membrane
   762   C0032112:Plasma cell [Cell]
   762   C3161472:Cell Membrane [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0032105:Plasma [Body Substance]
   742   C0596901:Membrane [Cell Component]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1706182:Membrane [Manufactured Object]

Phrase: "by a density gradient."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0178587:density [Quantitative Concept]
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.82: We found that the 2D polypeptide spot patterns of PM proteins isolated in this manner were highly reproducible within each cell line, with 2D gels from separate membrane isolations yielding spot patterns that are superimposable. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the 2D polypeptide spot patterns of PM proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449774:Patterns [Spatial Concept]
   728   C1317658:Protein pattern [Clinical Attribute]

Phrase: "isolated in this manner"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "highly reproducible within each cell line,"

Phrase: "with 2D gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "from separate membrane isolations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0204727:isolations [Therapeutic or Preventive Procedure]
   793 E C0205409:Isolation [Functional Concept]
   793 E C0220862:isolation [Laboratory Procedure]
   743 E C1548221:Isolated [Idea or Concept]

Phrase: "yielding"

Phrase: "spot patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "superimposable."
Processing 00000000.tx.83: In several comparisons of PM proteomes, we found the spot similarity within a cell line to be greater than 90%. 

Phrase: "In several comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "of PM proteomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the spot similarity within a cell line to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similarity [Qualitative Concept]

Phrase: "be"

Phrase: "greater than 90%."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.84: We also found that 2D gels of the PM proteome are substantially different from the spot patterns of corresponding whole cell lysates. 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that 2D gels of the PM proteome"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0017243:Gels [Biomedical or Dental Material]
   711 E C1382104:Gel [Substance]

Phrase: "are"

Phrase: "substantially different from the spot patterns of corresponding whole cell lysates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.85: For example, out of an average of 423 total spots, only 103 migrated to identical positions on the 2D gels when PM proteins were compared with a whole cell lysate (data not shown). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "out of an average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "of 423 total spots,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]

Phrase: "only 103"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "migrated to identical positions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205280:Identical [Qualitative Concept]
   770   C0232902:Migrated [Functional Concept]
   770   C0733755:positions [Spatial Concept]

Phrase: "on the 2D gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "when"

Phrase: "PM proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "were"

Phrase: "compared with a whole cell lysate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   753   C0007634:Cell [Cell]
   753   C0444667:Whole [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1707455:Compared [Activity]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: On the basis of these findings, we elected to enrich for PM proteins by using this purification strategy. 

Phrase: "On the basis of these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "elected"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enrich for PM proteins"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   845   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0007603:Plasma membrane [Cell Component]
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C1168405:protein plasma [Laboratory Procedure]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0359583:Enrich [Food]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this purification strategy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]
Processing 00000000.tx.87: Another consideration in the analysis is the ability of 2D gels to resolve integral membrane proteins. 

Phrase: "Another consideration in the analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0518609:consideration [Finding]

Phrase: "is"

Phrase: "the ability of 2D gels to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "integral membrane proteins."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0443238:Integral [Quantitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.88: We followed methods recently described by Rabilloud et al. 

Phrase: "We"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "methods recently"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "described by Rabilloud et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.89: (26) and Pasquali et al. 

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "Pasquali et al."
Processing 00000000.tx.90: (22), which show that the inclusion of thiourea in the extraction buffer significantly expands the range of integral membrane proteins that can be analyzed by 2D PAGE. 

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the inclusion of thiourea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512693:Inclusion [Qualitative Concept]

Phrase: "in the extraction buffer significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "expands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "the range of integral membrane proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "analyzed by 2D PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0032428:2D PAGE [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]
   770   C1705052:2D [Spatial Concept]
   770   C2986796:2D [Functional Concept]
Processing 00000000.tx.91: Our preliminary work confirmed that thiourea dramatically increased the number of spots visible on 2D gels of PM preparations (data not shown). 

Phrase: "Our preliminary work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that thiourea dramatically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039958:Thiourea [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the number of spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "visible on 2D gels of PM preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205379:Visible [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: However, initial mass fingerprinting of a number of spots on the gels identified few integral membrane proteins. 

Phrase: "However,"

Phrase: "initial mass fingerprinting of a number of spots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0016126:fingerprinting [Manufactured Object]

Phrase: "on the gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "few integral membrane proteins."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   861   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443238:Integral [Quantitative Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.93: By quantitative tracking of proteins tagged by cell surface iodination, we determined that less than 20% of the proteins on the external side of the membrane are actually resolved onto the second dimension gel (Table 2). 

Phrase: "By quantitative tracking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0546881:Tracking [Spatial Concept]
   827 E C0040594:Track [Manufactured Object]

Phrase: "of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "tagged by cell surface iodination,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0430302:Iodination [Laboratory Procedure]
   760   C0542502:Iodination [Natural Phenomenon or Process]
   760   C1269647:Cell [Cell]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1704653:Cell [Medical Device]
   760   C1708632:Tagged [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "we"

Phrase: "determined"

Phrase: "that less than 20% of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on the external side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "of the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "are"

Phrase: "actually"

Phrase: "resolved onto the second dimension gel"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0205436:Second [Quantitative Concept]
   753   C0439534:Dimension [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: Consequently, the first part of our analysis of the PM proteome was performed with the realization that the proteomes being compared consist primarily of proteins associated with the PM and that integral membrane proteins are likely to be under-represented. 

Phrase: "Consequently,"

Phrase: "the first part of our analysis of the PM proteome"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   772   C1820065:plasma membrane part [Cell Component]
   756   C1292711:Part of [Spatial Concept]
   754   C1513111:Membrane Part [Tissue]
   738   C0449719:Part [Spatial Concept]
   738   C1709471:Part [Quantitative Concept]
   718 E C1184749:Membranous part [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "performed with the realization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "that"

Phrase: "the proteomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "being"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "consist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332529:CONSIST [Qualitative Concept]

Phrase: "primarily of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with the PM"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "that integral membrane proteins"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0443238:Integral [Quantitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "under-represented."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0542339:Under [Spatial Concept]
   827   C1882932:Represent [Activity]
Processing 00000000.tx.95: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.96: Tracking 125I-labeled cell surface proteins through the 2D PAGE procedure  Identification of PM Signatures The PM proteomes of four fibroblast cell lines (Fig. 1, AD) and four breast cancer cell lines (Fig. 1, EH) were analyzed by 2D gel electrophoresis. 

Phrase: "Tracking 125I-labeled cell surface proteins through the 2D PAGE procedure  Identification"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0242392:Cell Surface Proteins [Amino Acid, Peptide, or Protein,Receptor]
   753   C0025252:Surface Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0699040:Cell surface [Cell Component]
   751   C2936595:Cell Tracking [Research Activity]
   736   C0007634:Cell [Cell]
   736   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205148:Surface [Spatial Concept]
   736   C1269647:Cell [Cell]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]

Phrase: "of PM Signatures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1514562:Signature [Amino Acid Sequence]
   793   C1519316:Signature [Intellectual Product]
   793   C1705596:Signature [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "The PM proteomes of four fibroblast cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "AD)"

Phrase: "and"

Phrase: "four breast cancer cell lines"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   884   C1512505:Breast Cancer Cell [Cell]
   840   C0006142:Breast Cancer [Neoplastic Process]
   840   C0007600:Cell lines [Cell]
   840   C0334227:Cancer Cell [Cell]
   840   C0678222:Breast Cancer [Neoplastic Process]
   831   C0230087:Mammary line [Body Location or Region]
   804   C0006141:Breast [Body Part, Organ, or Organ Component]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C0998265:Cancer [Eukaryote]
   804   C1268990:Breast [Body Part, Organ, or Organ Component]
   804   C1269647:Cell [Cell]
   804   C1306459:Cancer [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   790 E C0153661:thoracic cancer [Neoplastic Process]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
   748 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   748 E C1521735:Pectoral [Qualitative Concept]
   721 E C0817096:Chest [Body Location or Region]
   721 E C1527391:Chest [Body Location or Region]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "EH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "were"

Phrase: "analyzed by 2D gel electrophoresis."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0013860:Electrophoresis, Gel, 2D [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0936012:Analyzed [Research Activity]
   760   C1382104:Gel [Substance]
   760   C1705052:2D [Spatial Concept]
   760   C2986796:2D [Functional Concept]
Processing 00000000.tx.97: The polypeptide spot patterns of these gels, which contained an average of 360 spots per gel, were compared using computer-assisted spot matching. 

Phrase: "The polypeptide spot patterns of these gels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an average of 360 spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "per gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "computer-assisted spot matching."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0150103:MATCHING [Research Activity]
   812   C1708943:Matching [Qualitative Concept]
Processing 00000000.tx.98: Similarity between the PM proteomes was quantified by determining the percentage of matching spots between each gel pair. 

Phrase: "Similarity between the PM proteomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similarity [Qualitative Concept]

Phrase: "was"

Phrase: "quantified by determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the percentage of matching spots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "between each gel pair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.99: This pairwise comparison showed that cells of the same lineage exhibited remarkable similarity (Fig. 2), with similarity among the mammary carcinoma cell lines ranging from 38% to 55%. 

Phrase: "This pairwise comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that cells of the same lineage"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0282637:Cell Lineage [Idea or Concept]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "remarkable similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similarity [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "with similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similarity [Qualitative Concept]

Phrase: "among the mammary carcinoma cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   983   C0596890:mammary carcinoma cell line [Cell]
   886   C0230087:Mammary line [Body Location or Region]
   861   C0007600:Cell lines [Cell]
   861   C1518174:Carcinoma Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "ranging from 38%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 55%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.100: The similarity among the fibroblasts ranged from 18% to 40%, but most of the lines were nearly 30% identical. 

Phrase: "The similarity among the fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similarity [Qualitative Concept]

Phrase: "ranged from 18%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 40%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "but"

Phrase: "most of the lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205132:lines [Spatial Concept]
   770   C0205393:Most [Quantitative Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "nearly 30% identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.101: Conversely, cells of different lineage had far less similarity, with values ranging from only 9% to 23%. 

Phrase: "Conversely,"

Phrase: "cells of different lineage"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   802   C0282637:Cell Lineage [Idea or Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "far less similarity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "with values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "ranging from only 9%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 23%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.102: Altogether, these findings strongly suggest the presence of a PM "signature" that is tightly linked to cell lineage and that the signature of the mammary carcinoma cells constitutes a little under one-half of the PM proteome. 

Phrase: "Altogether,"

Phrase: "these findings strongly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a PM ""signature"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "is"

Phrase: "tightly"

Phrase: "linked to cell lineage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0282637:Cell Lineage [Idea or Concept]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1881379:Lineage [Conceptual Entity]
   770   C1948049:Cell [Spatial Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "that"

Phrase: "the signature of the mammary carcinoma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1514562:Signature [Amino Acid Sequence]
   748   C1519316:Signature [Intellectual Product]
   748   C1705596:Signature [Idea or Concept]

Phrase: "constitutes"

Phrase: "a little under one-half of the PM proteome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C2984078:A Little [Intellectual Product]
   739   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   739   C0700321:Little [Quantitative Concept]
   739   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.103: View larger version (124K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(124K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.104: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.105: Comparison of plasma membrane (PM) proteins by two-dimensional (2D) PAGE. 

Phrase: "Comparison of plasma membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "(PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: "proteins by two-dimensional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: "PAGE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]
Processing 00000000.tx.106: PMs were isolated from four fibroblast (AD; Hs 58.Fs, HE-SK, CCD-1090Sk, and Detroit 551) and four mammary carcinoma cell lines (EH; MCF7, MDA-MB-231, MDA-MB-435, and SK-BR-3). 

Phrase: "PMs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033046:PMS [Disease or Syndrome]
  1000   C1418866:PmS [Gene or Genome]
  1000   C1868117:PMS [Disease or Syndrome]

Phrase: "were"

Phrase: "isolated from four fibroblast"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0016030:Fibroblast [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C0205450:Four [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(AD"

Phrase: "; Hs 58.Fs,"

Phrase: "HE-SK,"

Phrase: "CCD-1090Sk,"

Phrase: "and"

Phrase: "Detroit 551"

Phrase: ")"

Phrase: "and"

Phrase: "four mammary carcinoma cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   921   C0596890:mammary carcinoma cell line [Cell]
   858   C0230087:Mammary line [Body Location or Region]
   840   C0007600:Cell lines [Cell]
   840   C1518174:Carcinoma Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "(EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "; MCF7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596890:MCF7 [Cell]

Phrase: "MDA-MB-231,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   827   C0026374:MDA [Geographic Area]

Phrase: "MDA-MB-435,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   827   C0026374:MDA [Geographic Area]

Phrase: "and"

Phrase: "SK-BR-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704648:Br. [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.107: Following membrane isolation, proteins were solubilized with a mixture of chaotropic and reducing agents and detergent as described in MATERIALS AND METHODS. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "membrane isolation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "solubilized with a mixture of chaotropic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "reducing agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0376446:Reducing Agents [Indicator, Reagent, or Diagnostic Aid]
   861   C0392756:Reducing [Qualitative Concept]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "detergent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]

Phrase: "as"

Phrase: "described in MATERIALS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.108: A total of 100 g of protein from this PM preparation was analyzed by 2D PAGE. 

Phrase: "A total of 100 g of protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0439177:Protein.total [Quantitative Concept]
   774   C0555903:Total protein [Laboratory Procedure]
   774   C1261360:total protein [Laboratory or Test Result]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]

Phrase: "from this PM preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "was"

Phrase: "analyzed by 2D PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0032428:2D PAGE [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]
   770   C1705052:2D [Spatial Concept]
   770   C2986796:2D [Functional Concept]
Processing 00000000.tx.109: Samples were focused in immobilized pH gradient (IPG) strips with a linear pH range of 47 and then were separated on a 12% acrylamide gel. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "focused in immobilized pH gradient"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1138565:pH gradient [Quantitative Concept]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0205234:Focused [Spatial Concept]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1285542:focused [Functional Concept]

Phrase: "(IPG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1138565:pH gradient [Quantitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   827   C0812409:Gradient [Quantitative Concept]

Phrase: ")"

Phrase: "strips with a linear pH range of 47"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0020283:[pH] [Quantitative Concept]
   744   C0205132:Linear [Spatial Concept]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C1321564:Strip [Medical Device]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "separated on a 12% acrylamide gel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]
Processing 00000000.tx.110: Gels were silver stained and scanned, and the resulting image was analyzed using ImageMaster Analysis software. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "silver stained"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
   861   C2986582:Stained [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "scanned,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "the resulting image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ImageMaster Analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.111: Only spots that constituted greater than 0.04% of the total staining density within the gel were considered for analysis. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "that constituted greater than 0.04% of the total staining density"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0439093:Greater Than [Quantitative Concept]
   738   C0443228:greater [Quantitative Concept]
   738   C1704243:Greater [Quantitative Concept]
   704 E C0549177:Great [Quantitative Concept]

Phrase: "within the gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "were"

Phrase: "considered for analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0750591:considered [Idea or Concept]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.112: All of the protein spots used for comparative analysis are shaded dark. 

Phrase: "All of the protein spots"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0329155:Spot [Fish]
   760   C0444868:All [Quantitative Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]
   760   C3539085:All [Idea or Concept]

Phrase: "used for comparative analysis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0683941:comparative analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "shaded"

Phrase: "dark."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]
Processing 00000000.tx.113: Each gel is representative of at least three replicate gels.  

Phrase: "Each gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "is"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three replicate gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]
Processing 00000000.tx.114: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.115: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.116: Similarity in the PM proteomes of fibroblasts and mammary carcinoma cells. 

Phrase: "Similarity in the PM proteomes of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "mammary carcinoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0678222:Mammary Carcinoma [Neoplastic Process]
Processing 00000000.tx.117: To assess the similarities among the PM proteomes of fibroblasts (Fib) and mammary carcinoma cells (MCC), the polypeptide spot pattern of each 2D gel was compared with that of every other gel in a pairwise fashion. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the similarities among the PM proteomes of fibroblasts (Fib)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "mammary carcinoma cells (MCC),"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0678222:Mammary Carcinoma [Neoplastic Process]

Phrase: "the polypeptide spot pattern of each 2D gel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "compared with that of every"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "other gel in a pairwise fashion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]
Processing 00000000.tx.118: Computer-assisted comparisons were made with ImageMaster analysis software as described in MATERIALS AND METHODS. 

Phrase: "Computer-assisted comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1707455:Comparison [Activity]
   734   C2362103:Computer assisted [Laboratory Procedure]

Phrase: "were"

Phrase: "made with ImageMaster analysis software"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0037585:Software [Intellectual Product,Manufactured Object]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "as"

Phrase: "described in MATERIALS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.119: The degree of similarity between two cell lines is reported as a percentage (% Identity), calculated by dividing the number of matching spots by the average number of spots on each gel pair.  

Phrase: "The degree of similarity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "between two cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "reported as a percentage"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0439165:Percentage [Quantitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(% Identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: ")"

Phrase: ","

Phrase: "calculated by dividing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332849:dividing [Functional Concept]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "the number of matching spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "by the average number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "on each gel pair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.120: As an additional assessment of the relatedness among cell lines, the relative abundance of a set of 83 proteins common to the PM of the mammary carcinoma lines, but absent from the fibroblasts, was compared. 

Phrase: "As an additional assessment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2359834:Additional assessment [Health Care Activity]
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]

Phrase: "of the relatedness"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   928   C0439849:Related [Qualitative Concept]
   928   C0445223:Related [Finding]
   900 E C0080103:Relation [Family Group]
   900 E C0869014:Relations [Social Behavior]

Phrase: "among cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "the relative abundance of a set of 83 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2346714:Abundance [Qualitative Concept]

Phrase: "common to the PM of the mammary carcinoma lines,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1333128:Common Carcinoma [Neoplastic Process]
   739   C0205214:Common [Quantitative Concept]
   739   C1522138:Common [Functional Concept]
   739   C3245511:common [Intellectual Product]

Phrase: "but"

Phrase: "absent from the fibroblasts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.121: The relative abundance of each protein was estimated by dividing its spot density by the combined spot density of all proteins on the gel. 

Phrase: "The relative abundance of each protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundance [Qualitative Concept]

Phrase: "was"

Phrase: "estimated by dividing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332849:dividing [Functional Concept]
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "its spot density by the combined spot density of all proteins"

Phrase: "on the gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.122: Differences in the relative abundance of individual proteins among the cell lines were generally small, falling within a two- to fourfold range (data not shown). 

Phrase: "Differences in the relative abundance of individual proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0021228:Individual Differences [Mental Process]
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "among the cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "generally small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "falling within a two-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0085639:FALLING [Finding]
   770   C0205448:Two [Quantitative Concept]
   737 E C0238715:Fall [Temporal Concept]

Phrase: "to fourfold range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: This suggests that most of the proteins in the PM signature of mammary carcinoma are expressed at similar levels. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that most of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the PM signature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1514562:Signature [Amino Acid Sequence]
   827   C1519316:Signature [Intellectual Product]
   827   C1705596:Signature [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "of mammary carcinoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0678222:Mammary Carcinoma [Neoplastic Process]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C0929301:Mammary [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "expressed at similar levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.124: Identification of Proteins in the Metastatic Signature Because the MDA-MB-435 cells are far more invasive than the MDA-MB-231 cells and the MCF7 cells, we sought to identify proteins unique to the PM proteome of the MDA-MB-435 cells. 

Phrase: "Identification of Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "in the Metastatic Signature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514562:Signature [Amino Acid Sequence]
   861   C1519316:Signature [Intellectual Product]
   861   C1705596:Signature [Idea or Concept]

Phrase: "Because"

Phrase: "the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "far more invasive than the MDA-MB-231 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205281:Invasive [Qualitative Concept]

Phrase: "and"

Phrase: "the MCF7 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0596890:MCF7 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "unique to the PM proteome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710548:Unique [Qualitative Concept]

Phrase: "of the MDA-MB-435 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.125: The mammary carcinoma cell line, SK-BR-3, was not included in this analysis because its metastatic properties are not defined. 

Phrase: "The mammary carcinoma cell line,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0596890:mammary carcinoma cell line [Cell]
   902   C0230087:Mammary line [Body Location or Region]
   861   C0007600:Cell Line [Cell]
   861   C1518174:Carcinoma Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "SK-BR-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704648:Br. [Conceptual Entity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included in this analysis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "because"

Phrase: "its metastatic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.126: We reasoned that this unique set of proteins might be linked to the metastatic phenotype. 

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that"

Phrase: "this unique set of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "linked to the metastatic phenotype."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0036525:Metastatic to [Functional Concept]
           Metastatic
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1522484:metastatic [Quantitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.127: We found 82 polypeptide spots in the PM proteome of the MDA-MB-435 cells that were not detected in the other two mammary carcinoma cells lines (Fig. 3). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "82 polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "spots in the PM proteome of the MDA-MB-435 cells"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   753   C0007603:Plasma membrane [Cell Component]
           cells membrane
   751   C0032112:Plasma Cells [Cell]
   736   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   736   C0007634:Cells [Cell]
   736   C0015230:spots [Disease or Syndrome]
   736   C0025255:Membrane [Tissue]
   736   C0026374:MDA [Geographic Area]
   736   C0032105:Plasma [Body Substance]
   736   C0329155:Spot [Fish]
   736   C0596901:Membrane [Cell Component]
   736   C0751973:Proteome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0848332:Spots [Sign or Symptom]
   736   C1427618:SPOT [Gene or Genome]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C1705203:Spot [Conceptual Entity]
   736   C1706182:Membrane [Manufactured Object]
   736   C3282337:Cells [Cell]
   734 E C3161472:Cell Membrane [Cell Component]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "other two mammary carcinoma cells lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   915   C0596890:mammary carcinoma cell line [Cell]
   858   C0230087:Mammary line [Body Location or Region]
   840   C0007600:cells lines [Cell]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.128: The fact that these spots are only observed in the MDA-MB-435 cells indicates that they are either uniquely expressed by these cells or that the MDA-MB-435 cells express a uniquely processed variant of each protein. 

Phrase: "The fact"

Phrase: "that"

Phrase: "these spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "are"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in the MDA-MB-435 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C0026374:MDA [Geographic Area]
   748   C1441672:Observed [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "either uniquely"

Phrase: "expressed by these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "that"

Phrase: "the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "a uniquely processed variant of each protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.129: Only a few of these unique polypeptides were present at sufficient levels for identification by peptide mass fingerprinting (Fig. 3, AE). 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few of these unique polypeptides"

Phrase: "were"

Phrase: "present at sufficient levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "for identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "by peptide mass fingerprinting"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C0030944:Peptide Fingerprinting [Laboratory Procedure]
   896 E C0016128:Peptide Fingerprint [Laboratory Procedure]
   827   C0016126:fingerprinting [Manufactured Object]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "AE"

Phrase: ")."
Processing 00000000.tx.130: Nevertheless, the results from mass fingerprinting of these proteins (Table 3) reveal some interesting observations. 

Phrase: "Nevertheless,"

Phrase: "the results from mass fingerprinting of these proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "some interesting observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.131: The potential function of each of the identified proteins in tumor progression is discussed below. 

Phrase: "The potential function of each of the identified proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   762   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   745 E C1527118:Protein Function [Molecular Function]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]

Phrase: "in tumor progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178874:Tumor Progression [Neoplastic Process]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "is"

Phrase: "discussed below."
Processing 00000000.tx.132: View larger version (114K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(114K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.134: Toward the identification of a metastatic proteome. 

Phrase: "Toward the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of a metastatic proteome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0751973:Proteome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.135: Spot comparisons were performed among the PM proteomes of the mammary carcinoma cells to identify polypeptide spots unique to the 2D gel of the highly metastatic MDA-MB-435 cells. 

Phrase: "Spot comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "performed among the PM proteomes of the mammary carcinoma cells to"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   753   C0007603:Plasma membrane [Cell Component]
           cells membrane
   753   C0678222:Mammary Carcinoma [Neoplastic Process]
   751   C0032112:Plasma Cells [Cell]
   736   C0006141:Mammary [Body Part, Organ, or Organ Component]
   736   C0007097:Carcinoma [Neoplastic Process]
   736   C0007634:Cells [Cell]
   736   C0025255:Membrane [Tissue]
   736   C0032105:Plasma [Body Substance]
   736   C0596901:Membrane [Cell Component]
   736   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0884358:Performed [Functional Concept]
   736   C0929301:Mammary [Body Part, Organ, or Organ Component]
   736   C1518174:Carcinoma Cell [Cell]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C1706182:Membrane [Manufactured Object]
   736   C3282337:Cells [Cell]
   734 E C3161472:Cell Membrane [Cell Component]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]
   703 E C2947996:Perform [Pharmacologic Substance]

Phrase: "identify"

Phrase: "polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "unique to the 2D gel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710548:Unique [Qualitative Concept]

Phrase: "of the highly metastatic MDA-MB-435 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.136: For the purpose of illustration, the position of the unique spots is shown on the 2D gel of MDA-MB-435 cells (in red) compared with a gel of the MDA-MB-231 cells. 

Phrase: "For the purpose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "of illustration,"

Phrase: "the position of the unique spots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "is"

Phrase: "shown on the 2D gel of MDA-MB-435 cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   739   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   739   C0007634:Cells [Cell]
   739   C0017243:Gel [Biomedical or Dental Material]
   739   C0026374:MDA [Geographic Area]
   739   C1382104:Gel [Substance]
   739   C1705052:2D [Spatial Concept]
   739   C2986796:2D [Functional Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706   C1547282:Show [Intellectual Product]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "in red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "compared with a gel of the MDA-MB-231 cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   739   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   739   C0007634:Cells [Cell]
   739   C0017243:Gel [Biomedical or Dental Material]
   739   C0026374:MDA [Geographic Area]
   739   C1382104:Gel [Substance]
   739   C1707455:Compared [Activity]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.137: Further detail of the boxed areas is shown in the insets, with arrows referencing the comparable regions of the two gels. 

Phrase: "Further detail of the boxed areas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1522508:Detail [Qualitative Concept]
   753   C1561567:detail [Functional Concept]

Phrase: "is"

Phrase: "shown in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "insets"

Phrase: ","

Phrase: "with arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "referencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]

Phrase: "the comparable regions of the two gels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]
Processing 00000000.tx.138: The identities of spots AE were determined by mass spectrometry (Table 3).  

Phrase: "The identities of spots AE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0424215:identities [Mental Process]
   726 E C2003939:Identity [Finding]

Phrase: "were"

Phrase: "determined by mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.139: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.140: Identification of proteins from the MDA-MB-435 cells by mass spectrometry  The p47 subunit of eukaryotic initiation factor 3. 

Phrase: "Identification of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "from the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "by mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "The p47 subunit of eukaryotic initiation factor 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.141: Spot B in Fig. 

Phrase: "Spot B in Fig."
Processing 00000000.tx.142: 3 was found to be the p47 subunit of eukaryotic initiation factor 3 (eIF3). 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the p47 subunit of eukaryotic initiation factor 3 (eIF3)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.143: This protein migrated very near its predicted Mr and isoelectric point (pI), indicating that its presence in the PM proteome is due to upregulation in the MDA-MB-435 cells or to a unique association with the PM in these cells. 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "very near its predicted Mr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442824:Very [Qualitative Concept]
   760   C0681842:Predicted [Idea or Concept]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C2347167:Mr. [Conceptual Entity]

Phrase: "and"

Phrase: "isoelectric point (pI),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022171:Isoelectric Point [Quantitative Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "its presence in the PM proteome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is due to upregulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]
   770   C3146286:Due [Idea or Concept]

Phrase: "in the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "or to a unique association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1710548:Unique [Qualitative Concept]

Phrase: "with the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.144: The eIFs control protein synthesis by regulating the interaction between mRNA, tRNA, and ribosomes (21). 

Phrase: "The eIFs control protein synthesis by"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "regulating"

Phrase: "the interaction between mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "tRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.145: eIF3 is a multiprotein complex that binds to the 40S ribosomal subunit and is believed to regulate its association with the 60S ribosome (1). 

Phrase: "eIF3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752615:Eukaryotic Initiation Factor-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a multiprotein complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "binds to the 40S ribosomal subunit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1753319:40S ribosomal subunit [Cell Component]
   790   C1956015:ribosomal subunit [Cell Component]
   753   C0035553:Ribosomal [Cell Component]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "its association with the 60S ribosome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.146: Interestingly, the p47 subunit of the eIF3 complex was only recently cloned and was found to be homologous to a number of other proteins including Mov-34, a component of the 26S proteosome (1). 

Phrase: "Interestingly,"

Phrase: "the p47 subunit of the eIF3 complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "only recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "homologous to a number of other proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1512488:Homologous Protein [Amino Acid, Peptide, or Protein]
   748   C1334043:Homologous [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Mov-34,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413614:MOV-34 [Gene or Genome]
   861   C2825516:MOV [Quantitative Concept]

Phrase: "a component of the 26S proteosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.147: The function of p47 is not known, but its relationship to Mov-34 suggests that it may be involved in regulating subunit interactions within eIF3. 

Phrase: "The function of p47"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "its relationship to Mov-34"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "subunit interactions within eIF3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.148: Our identification of p47 in PM preparations also suggests that it could have a role outside of the eIF3 complex. 

Phrase: "Our identification of p47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "in PM preparations also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "have"

Phrase: "a role outside of the eIF3 complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.149: Such a novel function could explain its prevalence in PM fractions. 

Phrase: "Such"

Phrase: "a novel function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "could"

Phrase: "explain"

Phrase: "its prevalence in PM fractions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]
Processing 00000000.tx.150: Although the eIFs are not considered classic oncogenes, there is now an expanding body of literature indicating that misregulation of individual components of eIF2, eIF3, and eIF4 can lead to neoplastic transformation (6, 7, 17, 20, 27). 

Phrase: "Although"

Phrase: "the eIFs"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "classic oncogenes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogenes [Gene or Genome]

Phrase: "there"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "an expanding body of literature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "indicating"

Phrase: "that misregulation of individual components of eIF2,"

Phrase: "eIF3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752615:Eukaryotic Initiation Factor-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "eIF4"

Phrase: "can"

Phrase: "lead to neoplastic transformation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0007621:neoplastic transformation [Neoplastic Process]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0040682:Transformation [Cell Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1510411:Transformation [Pathologic Function]
   770   C1522538:Lead [Functional Concept]
   770   C1705163:Transformation [Research Activity]
   770   C1709160:Neoplastic [Qualitative Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(6,"

Phrase: "7,"

Phrase: "17,"

Phrase: "20,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.151: Although p47 of eIF3 has not been extensively studied, one might hypothesize that it could play a similar role in tumor progression. 

Phrase: "Although"

Phrase: "p47 of eIF3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0752615:Eukaryotic Initiation Factor-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "extensively"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "hypothesize"

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a similar role in tumor progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.152: An uncharacterized protein, p25. 

Phrase: "An uncharacterized protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "p25."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p25 [Gene or Genome]
Processing 00000000.tx.153: We also observed a 25-kDa protein (spot C, Fig. 3) that is unique to the PM proteome of the MDA-MB-435 cells. 

Phrase: "We also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a 25-kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(spot C,"

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "unique to the PM proteome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710548:Unique [Qualitative Concept]

Phrase: "of the MDA-MB-435 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.154: Peptide mass fingerprinting showed this protein to be identical to three nucleotide sequences that were independently deposited in the databases (GenBank accession nos. AAD27784, BAA76626, and AAD40193). 

Phrase: "Peptide mass fingerprinting"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C0030944:Peptide Fingerprinting [Laboratory Procedure]
   896 E C0016128:Peptide Fingerprint [Laboratory Procedure]
   827   C0016126:fingerprinting [Manufactured Object]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "this protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "be"

Phrase: "identical to three nucleotide sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "independently"

Phrase: "deposited in the databases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0242356:Databases [Intellectual Product]
   770   C0333562:deposited [Functional Concept]
   737 E C0993637:Database [Intellectual Product]

Phrase: "(GenBank accession nos. AAD27784,"

Phrase: "BAA76626,"

Phrase: "and"

Phrase: "AAD40193"

Phrase: ")."
Processing 00000000.tx.155: The predicted mass of the protein derived from each of these genes matches the migration position of p25 on 2D gels. 

Phrase: "The predicted mass of the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "derived from each of these genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017337:Genes [Gene or Genome]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "matches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0150103:match [Research Activity]
  1000   C0336766:Matches [Manufactured Object]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "the migration position of p25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:Position [Spatial Concept]

Phrase: "on 2D gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]
Processing 00000000.tx.156: Expressed sequence tags encoding the protein are found in several tissues. 

Phrase: "Expressed sequence tags"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0600510:Expressed Sequence Tags [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "found in several tissues."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040300:Tissues [Tissue]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   737 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.157: However, to our knowledge this is the first demonstration that the protein product of the gene is expressed. 

Phrase: "However,"

Phrase: "to our knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first demonstration"

Phrase: "that"

Phrase: "the protein product of the gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0751455:protein gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "expressed."
Processing 00000000.tx.158: This protein lacks homology to any other known protein or gene in the databases and has no known function. 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "homology to any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1334043:Homology [Gene or Genome]
   790   C2697616:Homology [Qualitative Concept]

Phrase: "other known protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "gene in the databases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "has"

Phrase: "no known function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.159: -Synuclein. 

Phrase: "-Synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.160: Spot D in Fig. 

Phrase: "Spot D in Fig."
Processing 00000000.tx.161: 3 was found to be -synuclein. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.162: This protein also migrated close to its predicted Mr and pI in the 2D gels from MDA-MB-435 cells. 

Phrase: "This protein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "close to its predicted Mr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0587267:Close [Functional Concept]

Phrase: "and"

Phrase: "pI in the 2D gels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "from MDA-MB-435 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.163: Synucleins are small cytoplasmic proteins of 130 amino acids. 

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "small cytoplasmic proteins of 130 amino acids."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1874187:AMINO ACIDS/PROTEINS [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   761   C1824324:small acidic protein [Gene or Genome]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.164: Although their precise biological function is still poorly understood, the synucleins (, , and ) contain lipid binding helices that bind to acidic phospholipids in vitro (5). 

Phrase: "Although"

Phrase: "their precise biological function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0031845:Biological function, NOS [Physiologic Function]
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0031843:function [Physiologic Function]
   827   C0205460:biological [Qualitative Concept]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "still poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205169:Poorly [Qualitative Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "the synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(,"

Phrase: ","

Phrase: "and )"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "lipid binding helices"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0018882:Helix [Eukaryote]
   827   C0229304:Helix [Body Part, Organ, or Organ Component]
   827   C1017315:helices [Eukaryote]
   827   C1704821:Helix [Spatial Concept]
   827   C1705682:Helix [Anatomical Structure]
   734   C1148636:Lipid Binding [Molecular Function]

Phrase: "that"

Phrase: "bind to acidic phospholipids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0001128:Acidic [Chemical]
   770   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   737 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.165: The prevailing notion is that synucleins have some function at the inner leaf of the PM. 

Phrase: "The prevailing notion"

Phrase: "is"

Phrase: "that synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "some function at the inner leaf of the PM."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0682568:membrane function [Body Part, Organ, or Organ Component]
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
Processing 00000000.tx.166: -Synuclein was originally identified as the precursor protein for the non- amyloid component of Alzheimers disease amyloid plaques (30), and a variant of -synuclein appears to be responsible for a rare genetic from of Parkinsons disease (24). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "originally"

Phrase: "identified as the precursor protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "for the non- amyloid component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "of Alzheimers disease amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   861   C2936349:Plaques, Amyloid [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a variant of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "responsible for a rare genetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "from"

Phrase: "of Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.167: However, the mechanistic role of these proteins in the pathology of these diseases is unknown. 

Phrase: "However,"

Phrase: "the mechanistic role of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "of these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.168: Synucleins are not expressed in normal breast epithelia, but both - and -synuclein are expressed in the vast majority of ductal carcinomas of the breast (3). 

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed in normal breast epithelia,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0567498:Normal breast [Finding]
   762   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   760   C0006141:Breast [Body Part, Organ, or Organ Component]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1268990:Breast [Body Part, Organ, or Organ Component]
   760   C2347086:% Normal [Quantitative Concept]
   726   C0014609:Epithelium [Tissue]
   704 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   704 E C1521735:Pectoral [Qualitative Concept]

Phrase: "but"

Phrase: "both -"

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed in the vast majority of ductal carcinomas of the breast"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   796   C1527349:Ductal Carcinoma of the Breast [Neoplastic Process]
           Ductal Carcinoma of Breast
           Ductal Breast Carcinoma
       E   Ductal Carcinoma
   778   C0678222:Carcinoma of the Breast [Neoplastic Process]
           Carcinoma of breast
           breast carcinomas
   759   C0021367:ductal breast carcinoma [Neoplastic Process]
   756   C1176475:Ductal Carcinomas [Neoplastic Process]
   755 E C1134719:Carcinoma, Ductal, Breast [Neoplastic Process]
   738   C0006141:Breast [Body Part, Organ, or Organ Component]
   738   C0007097:Carcinomas [Neoplastic Process]
   738   C0680220:majority [Social Behavior]
   738   C0814230:VAST [Intellectual Product]
   738   C1268990:Breast [Body Part, Organ, or Organ Component]
   738   C1512083:Ductal [Qualitative Concept]
   737 E C0006142:Breast Carcinoma [Neoplastic Process]
   718   C1116428:Breast Duct [Body Part, Organ, or Organ Component]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.169: The role of synucleins in tumor progression remains unclear, but it is worth noting that transfection of the MDA-MB-435 cells with -synuclein was reported to increase the metastatic potential of this cell line (11). 

Phrase: "The role of synucleins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in tumor progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178874:Tumor Progression [Neoplastic Process]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "remains"

Phrase: "unclear,"

Phrase: "but"

Phrase: "it"

Phrase: "is worth noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "that transfection of the MDA-MB-435 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the metastatic potential of this cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.170: Our finding that -synuclein is unique to the PM proteome of the MDA-MB-435 cells underscores the need to understand the function of this family of proteins in metastatic spread. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "unique to the PM proteome of the MDA-MB-435 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1710548:Unique [Qualitative Concept]

Phrase: "underscores"

Phrase: "the need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the function of this family of proteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   774   C0680051:family function [Social Behavior]
   774   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   757 E C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "in metastatic spread."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332261:Spread [Qualitative Concept]
   861   C1947932:Spread [Activity]
Processing 00000000.tx.171: Galectin-1. 

Phrase: "Galectin-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.172: Galectin-1, a mammalian lectin that binds to -galactoside, was also found to be unique to the PM proteome of MDA-MB-435 cells (spot E, Fig. 3). 

Phrase: "Galectin-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a mammalian lectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023206:Lectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to -galactoside,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016956:galactoside [Carbohydrate]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "unique to the PM proteome of MDA-MB-435 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1710548:Unique [Qualitative Concept]

Phrase: "(spot E,"

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.173: Galectin-1 migrated at its predicted Mr and pI in the 2D gel. 

Phrase: "Galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrated at its predicted Mr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0232902:Migrated [Functional Concept]
   760   C0681842:Predicted [Idea or Concept]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C2347167:Mr. [Conceptual Entity]

Phrase: "and"

Phrase: "pI in the 2D gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
Processing 00000000.tx.174: Galectin-1 can be secreted from cells and then is able to bind back to glycosylated proteins on the PM. 

Phrase: "Galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "secreted from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1327616:Secreted [Cell Function]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "back to glycosylated proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004600:Back [Body Location or Region]
   770   C0205095:Back [Spatial Concept]
   770   C0460009:Back [Body Location or Region]
   770   C1995000:Back [Body Location or Region]

Phrase: "on the PM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.175: Galectin-1 is upregulated in several cancers, and its expression is often higher in more differentiated tumors (33, 34). 

Phrase: "Galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "upregulated in several cancers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006826:Cancer [Neoplastic Process]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "its expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "often higher in more differentiated tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.176: Galectin-1 exists as a homodimer and can facilitate intramolecular and intermolecular cross-bridging. 

Phrase: "Galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exists as a homodimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "can"

Phrase: "facilitate"

Phrase: "intramolecular"

Phrase: "and"

Phrase: "intermolecular cross-bridging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0456378:Bridge [Medical Device]
Processing 00000000.tx.177: Such cross-bridging may facilitate cellular signaling through growth factor receptors or may mediate cell-cell adhesion (23). 

Phrase: "Such cross-bridging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456378:Bridge [Medical Device]

Phrase: "may"

Phrase: "facilitate"

Phrase: "cellular signaling through growth factor receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1514762:Receptor Signaling [Molecular Function]
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "or"

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell-cell adhesion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1154382:cell-cell adhesion [Cell Function]
   913   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.178: Interestingly, galectin-1 has been shown to mediate the adhesion of MDA-MB-435 cells to human endothelial cells, and this has been proposed as a key route to metastatic spread (8). 

Phrase: "Interestingly,"

Phrase: "galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the adhesion of MDA-MB-435 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to human endothelial cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0086418:Human [Human]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "proposed as a key route"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0013153:ROUTE [Functional Concept]
   760   C0449444:Route [Spatial Concept]
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]
   760   C1879941:ROUTE [Intellectual Product]

Phrase: "to metastatic spread"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332261:Spread [Qualitative Concept]
   861   C1947932:Spread [Activity]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.179: Our observation that galectin-1 is unique to the PM proteome of MDA-MB-435 cells lends further support to the idea that galectin-1 is connected to metastasis. 

Phrase: "Our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "unique to the PM proteome of MDA-MB-435 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1710548:Unique [Qualitative Concept]

Phrase: "lends"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support to the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0183683:Support [Medical Device]
   770   C1521721:Support [Conceptual Entity]

Phrase: "that galectin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0252527:Galectin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416829:GALECTIN 1 [Gene or Genome]
   861   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "connected to metastasis."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   822   C0036525:Metastatic to [Functional Concept]
       E   Metastatic
   790   C0027627:Metastasis [Neoplastic Process]
   790   C2939420:metastasis [Neoplastic Process]
   756   C2986575:Connect [Activity]
   718 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.180: Thiol-specific antioxidant protein. 

Phrase: "Thiol-specific antioxidant protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0633227:Thiol-Specific Antioxidant Protein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.181: Eighty polypeptide spots were observed to be present in the PM preparations of MDA-MB-231 cells and MCF7 cells but were undetectable in the PM preparation of the metastatic MDA-MB-435 cells. 

Phrase: "Eighty polypeptide spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in the PM preparations of MDA-MB-231 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0150312:Present [Quantitative Concept]
   738   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "MCF7 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0596890:MCF7 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "were"

Phrase: "undetectable in the PM preparation"

Phrase: "of the metastatic MDA-MB-435 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.182: This finding suggests that downregulation of large sets of proteins may make an equally important contribution to the metastatic phenotype. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that downregulation of large sets of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "may"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "an equally important contribution to the metastatic phenotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]
Processing 00000000.tx.183: One of these proteins was identified from the MCF7 and MDA-MB-231 cells by mass fingerprinting. 

Phrase: "One of these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "identified from the MCF7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C0596890:MCF7 [Cell]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "MDA-MB-231 cells by mass fingerprinting."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.184: It was found to be thiol-specific antioxidant protein (TSA). 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "thiol-specific antioxidant protein (TSA)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0633227:Thiol-Specific Antioxidant Protein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.185: TSA presumably has a role in protecting cells against oxidative damage (35). 

Phrase: "TSA presumably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   937   C0633227:Thiol-Specific Antioxidant Protein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "a role in protecting cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "against oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.186: This observation is consistent with a prior report showing that the TSA gene is downregulated in MDA-MB-435 cells compared with MDA-MB-231 and MCF7 cells (12).  

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "consistent with a prior report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the TSA gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   771   C0633227:Thiol-Specific Antioxidant Protein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "downregulated in MDA-MB-435 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   753   C0007634:Cells [Cell]
   753   C0026374:MDA [Geographic Area]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "compared with MDA-MB-231"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   760   C0026374:MDA [Geographic Area]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "MCF7 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0596890:MCF7 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.187: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The primary objective of this study was to obtain basic information on the similarities and differences among PM proteomes. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The primary objective of this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2985627:Study Objective [Idea or Concept]
   753   C0018017:Objective [Intellectual Product]
   753   C1571702:Objective [Qualitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "basic information on the similarities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "differences among PM proteomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.188: One might hypothesize that cells with similar lineage, or phenotype, would exhibit a high degree of similarity at the PM. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "hypothesize"

Phrase: "that cells with similar lineage,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0282637:Cell Lineage [Idea or Concept]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "would"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a high degree of similarity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "at the PM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.189: However, to our knowledge, there has been no information published on this topic. 

Phrase: "However,"

Phrase: "to our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "no information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "published on this topic."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034037:Published [Occupational Activity]
   770   C1522168:TOPIC [Functional Concept]
   770   C1555712:topic [Idea or Concept]
   770   C1704324:Published [Intellectual Product]
Processing 00000000.tx.190: The findings of the present study indicate that there are indeed signatures of proteins at the PM. 

Phrase: "The findings of the present study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0683954:study findings [Finding]
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that there"

Phrase: "are"

Phrase: "indeed signatures of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   786   C3463810:protein signature [Laboratory or Test Result]
   737   C1514562:Signature [Amino Acid Sequence]
   737   C1519316:Signature [Intellectual Product]
   737   C1705596:Signature [Idea or Concept]

Phrase: "at the PM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.191: In general, the proteins at the PM can be segregated into three groups. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the proteins at the PM"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C1168405:protein plasma [Laboratory Procedure]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "segregated into three groups."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205449:Three [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
Processing 00000000.tx.192: One group of proteins is likely to be common to most cell types. 

Phrase: "One group of proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "common to most cell types."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C3242448:common types [Intellectual Product]
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.193: We found that between 9% and 23% of all proteins at the PMs of fibroblasts and mammary carcinoma cells migrate to the same position on 2D gels and are likely to be identical. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that between 9%"

Phrase: "and"

Phrase: "23% of all proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450348:23 [Quantitative Concept]

Phrase: "at the PMs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033046:PMS [Disease or Syndrome]
  1000   C1418866:PmS [Gene or Genome]
  1000   C1868117:PMS [Disease or Syndrome]

Phrase: "of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "and"

Phrase: "mammary carcinoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0678222:Mammary Carcinoma [Neoplastic Process]

Phrase: "migrate to the same position"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0232902:migrate [Functional Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0733755:Position [Spatial Concept]

Phrase: "on 2D gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.194: Given the functional distinction between these two types of cells, it seems reasonable to suggest that this common set of PM proteins is widely expressed among most cell types. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the functional distinction between these two types of cells,"

Phrase: "it"

Phrase: "seems"

Phrase: "reasonable to"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this common set of PM proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036849:Set [Mental Process]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "is"

Phrase: "widely"

Phrase: "expressed among most cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.195: A second set of PM proteins appears to be linked with cell lineage. 

Phrase: "A second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of PM proteins"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   845   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0007603:Plasma membrane [Cell Component]
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C1168405:protein plasma [Laboratory Procedure]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036849:Set [Mental Process]
   760   C0596901:Membrane [Cell Component]
   760   C1442518:Set [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1705195:Set [Conceptual Entity]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked with cell lineage."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0282637:Cell Lineage [Idea or Concept]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1881379:Lineage [Conceptual Entity]
   770   C1948049:Cell [Spatial Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.196: From our 2D gel study, we found that between 38% and 55% of the proteins at the PM of mammary carcinoma are identical. 

Phrase: "From our 2D gel study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that between 38%"

Phrase: "and"

Phrase: "55% of the proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007507:Protein 55 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450382:55 [Intellectual Product]

Phrase: "at the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "of mammary carcinoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0678222:Mammary Carcinoma [Neoplastic Process]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C0929301:Mammary [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.197: The similarity among fibroblasts was somewhat lower, ranging from 18% to 40%. 

Phrase: "The similarity among fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similarity [Qualitative Concept]

Phrase: "was"

Phrase: "somewhat lower,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "ranging from 18%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 40%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.198: The lower degree of similarity among the fibroblasts may be explained by the fact that fibroblasts are less differentiated and have functions that are less specialized than mammary epithelial cells. 

Phrase: "The lower degree of similarity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "among the fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the fact"

Phrase: "that fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "are"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "have"

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "specialized than mammary epithelial cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   827   C1519442:Specialized epithelial cell [Cell]
   806   C0014597:Epithelial Cells [Cell]
   806   C1273342:Epithelial Cells [Laboratory Procedure]
   760   C0006141:Mammary [Body Part, Organ, or Organ Component]
   760   C0007634:Cells [Cell]
   760   C0205555:specialized [Qualitative Concept]
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0929301:Mammary [Body Part, Organ, or Organ Component]
   760   C1704211:Specialized [Conceptual Entity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.199: One might expect that this set of proteins confer the overall character of the cell. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "expect"

Phrase: "that"

Phrase: "this set of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "confer"

Phrase: "the overall character of the cell."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007952:Character [Mental Process]
   753   C0486537:Character [Organism Attribute]
   753   C2350015:Character [Qualitative Concept]
Processing 00000000.tx.200: For example, in the case of mammary carcinoma cells, these proteins might be responsible for epithelial structure and function. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of mammary carcinoma cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1518174:Carcinoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0678222:Mammary Carcinoma [Neoplastic Process]

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "responsible for epithelial structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.201: This structure-function relationship, then, would clearly distinguish these cells from fibroblasts. 

Phrase: "This structure-function relationship,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   877   C0923800:Structural relationship [Conceptual Entity]
   865   C2700217:Functional Relationship [Conceptual Entity]
       E   Functional
   827   C0031843:function [Physiologic Function]
   827   C0439849:Relationship [Qualitative Concept]
   827   C0542341:Function [Functional Concept]
   827   C0678594:Structure [Spatial Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   827   C1705630:Relationship [Idea or Concept]
   827   C1706279:Relationship [Idea or Concept]
   827   C3540605:Relationship [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]

Phrase: "then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "would"

Phrase: "clearly"

Phrase: "distinguish"

Phrase: "these cells from fibroblasts."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   802   C0016030:cells fibroblast [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: A third group of proteins appears to be expressed uniquely on each individual cell line and be independent of cell lineage. 

Phrase: "A third group of proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed"

Phrase: "uniquely on each individual cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0027361:Individual [Population Group]
   753   C0205132:Line [Spatial Concept]
   753   C0237401:Individual [Human]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "be independent of cell lineage."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0282637:Cell Lineage [Idea or Concept]
   806   C0332291:Independent of [Functional Concept]
   760   C0007634:Cell [Cell]
   760   C0085862:Independent [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1299583:Independent [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1881379:Lineage [Conceptual Entity]
   760   C1948049:Cell [Spatial Concept]
   760   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.203: These proteins composed roughly 22% of all proteins in the PM preparations. 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "composed"

Phrase: "roughly 22% of all proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the PM preparations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]
   734   C0007603:Plasma membrane [Cell Component]
Processing 00000000.tx.204: When considering this set of proteins, it is important to emphasize the distinction between cell lineage and cellular phenotype. 

Phrase: "When"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "this set of proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "emphasize"

Phrase: "the distinction between cell lineage"

Phrase: "and"

Phrase: "cellular phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.205: Lineage, or the tissue source of a cell, clearly has a significant impact on the profile of proteins expressed by a cell. 

Phrase: "Lineage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881379:Lineage [Conceptual Entity]

Phrase: "or"

Phrase: "the tissue source of a cell,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "clearly"

Phrase: "has"

Phrase: "a significant impact on the profile of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "expressed by a cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.206: However, cells of similar lineage, like the MCF7 and MDA-MB-435 cells, can exhibit distinct phenotypes. 

Phrase: "However,"

Phrase: "cells of similar lineage,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   802   C0282637:Cell Lineage [Idea or Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "like the MCF7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596890:MCF7 [Cell]

Phrase: "and"

Phrase: "MDA-MB-435 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "distinct phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.207: This is particularly evident with cancer cells, which can represent any number of stages of tumor progression. 

Phrase: "This"

Phrase: "is"

Phrase: "particularly evident with cancer cells,"

Phrase: "which"

Phrase: "can"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "any number of stages of tumor progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.208: For example, the MCF7 cells will only grow as a primary tumor in mice when estrogen is supplemented. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the MCF7 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0596890:MCF7 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "will"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "grow as a primary tumor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0677930:Primary Tumor [Neoplastic Process]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "when"

Phrase: "estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "supplemented."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.209: In contrast, the MDA-MB-435 cells grow tumors independent of estrogen. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "grow"

Phrase: "tumors independent of estrogen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0027651:Tumors [Neoplastic Process]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]
Processing 00000000.tx.210: Furthermore, the MCF7 cells fail to metastasize, whereas the MDA-MB-435 cells exhibit extensive macroscopic metastases to multiple organs (25). 

Phrase: "Furthermore,"

Phrase: "the MCF7 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0596890:MCF7 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "metastasize"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027627:Metastasize [Neoplastic Process]
  1000   C2939420:metastasize [Neoplastic Process]

Phrase: ","

Phrase: "whereas"

Phrase: "the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "extensive macroscopic metastases to multiple organs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0027627:Metastases [Neoplastic Process]
   753   C2939419:Metastases [Neoplastic Process]
   748   C0036525:Metastatic to [Functional Concept]
   719 E C2939420:metastasis [Neoplastic Process]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.211: Although a clear lineage-specific signature is common among these two cell lines, it is not surprising that another set of proteins is different between the two. 

Phrase: "Although"

Phrase: "a clear lineage-specific signature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514562:Signature [Amino Acid Sequence]
   812   C1519316:Signature [Intellectual Product]
   812   C1705596:Signature [Idea or Concept]

Phrase: "is"

Phrase: "common among these two cell lines,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "that"

Phrase: "another"

Phrase: "set of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "is"

Phrase: "different between the two."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.212: Nearly one-fourth of all PM proteins appeared to be unique to individual cell lines. 

Phrase: "Nearly one-fourth of all PM proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205438:Fourth [Quantitative Concept]
   744   C1706303:Fourth [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "unique to individual cell lines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710548:Unique [Qualitative Concept]
Processing 00000000.tx.213: Our identification of a few of these proteins from the MDA-MB-435 cells, which show wide variation in their proposed functions, illustrates the scope of biochemical pathways that could be influenced by these differences. 

Phrase: "Our identification of a few of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "from the MDA-MB-435 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "wide variation in their proposed functions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "illustrates"

Phrase: "the scope of biochemical pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710028:Scope [Conceptual Entity]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "influenced by these differences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.214: For example, compared with the MCF7 and MDA-MB-231 cells, the MDA-MB-435 cells have undetectable levels of TSA, a key regulator of oxidant stress. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "compared with the MCF7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596890:MCF7 [Cell]
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "MDA-MB-231 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the MDA-MB-435 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "undetectable levels of TSA,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "a key regulator of oxidant stress."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.215: The MDA-MB-435 cells also differentially express proteins that could dramatically influence the kinetics of large groups of mRNAs, as well as proteins that could alter the character of the inner leaf of the PM. 

Phrase: "The MDA-MB-435 cells also differentially"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   799   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   799   C0007634:Cells [Cell]
   799   C0026374:MDA [Geographic Area]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "could"

Phrase: "dramatically"

Phrase: "influence"

Phrase: "the kinetics of large groups of mRNAs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022702:Kinetics [Natural Phenomenon or Process]
   748   C0220865:kinetics [Functional Concept]
   748   C2825046:Kinetics [Occupation or Discipline]

Phrase: "as well as"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "could"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the character of the inner leaf of the PM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0007952:Character [Mental Process]
   739   C0486537:Character [Organism Attribute]
   739   C2350015:Character [Qualitative Concept]
Processing 00000000.tx.216: Altogether, the functional scope of the cell-specific proteins appears to be immense and is consistent with the widely disparate phenotype of these mammary carcinoma cell lines. 

Phrase: "Altogether,"

Phrase: "the functional scope of the cell-specific proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710028:Scope [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "immense"

Phrase: "and"

Phrase: "is"

Phrase: "consistent with the widely disparate phenotype of these mammary carcinoma cell lines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.217: In the area of protein profiling there is a need to perform large-scale comparisons that provide both protein identity and protein abundance. 

Phrase: "In the area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "of protein profiling there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0444680:Protein profiling [Laboratory Procedure]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "a need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "large-scale comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "that"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "both protein identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "protein abundance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]
Processing 00000000.tx.218: The present report illustrates some of the difficulties and limitations encountered by a typical biochemistry laboratory in meeting these hurdles. 

Phrase: "The present report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "illustrates"

Phrase: "some of the difficulties"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C1299586:difficulties [Finding]
   770   C3540770:Some [Intellectual Product]

Phrase: "and"

Phrase: "limitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "encountered by a typical biochemistry laboratory"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0005477:Biochemistry [Occupation or Discipline]
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C3244292:laboratory [Functional Concept]
   753   C3538928:Typical [Qualitative Concept]
   719   C0545082:Encounter [Behavior]
   719   C1512346:encounter [Health Care Activity]
   719   C1947978:Encounter [Behavior]

Phrase: "in meeting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0556656:Meeting [Health Care Activity]

Phrase: "these hurdles."
Processing 00000000.tx.219: Although 2D gels represent the best technology available for protein separation, they clearly fall short in the separation of integral membrane proteins as well as true measurements of protein abundance. 

Phrase: "Although"

Phrase: "2D gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the best technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "available for protein separation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "they clearly"

Phrase: "fall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "short in the separation of integral membrane proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1282927:short [Qualitative Concept]
   744   C1806781:Short [Quantitative Concept]
   744   C2350002:Short [Quantitative Concept]

Phrase: "as well as"

Phrase: "true measurements of protein abundance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0202202:Protein measurement [Laboratory Procedure]
   760   C0242485:measurements [Functional Concept]
Processing 00000000.tx.220: Recent advances suggest that labeling of proteins within a mixture with isotope tags can be combined with mass spectrometry to obtain protein identity and abundance on a broad scale (9). 

Phrase: "Recent advances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0725066:Advance [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that labeling of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "within a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "with isotope tags"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1139855:tags [Medical Device]
   827 E C0037293:Tag [Neoplastic Process]
   827 E C0181496:Tag [Manufactured Object]
   827 E C1710492:TAG [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "combined with mass spectrometry to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0205195:Combined [Qualitative Concept]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "protein identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "abundance on a broad scale"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundance [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.221: Independent work indicates that combining protein digestion with highly sophisticated peptide mass analysis could yield a similar level of information (14). 

Phrase: "Independent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "indicates"

Phrase: "that combining protein digestion with highly sophisticated peptide mass analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1523943:protein digestion [Organism Function]
   760   C2349986:Protein Digestion [Research Activity]
           Digestion
   739   C0012238:Digestion [Organism Function]

Phrase: "could"

Phrase: "yield"

Phrase: "a similar level of information"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.222: Despite the appeal of each of these strategies, they all require significant technological expertise and resources. 

Phrase: "Despite the appeal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680651:appeal [Governmental or Regulatory Activity]

Phrase: "of each"

Phrase: "of these strategies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategies [Mental Process]

Phrase: "they"

Phrase: "all"

Phrase: "require"

Phrase: "significant technological expertise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870520:expertise [Qualitative Concept]

Phrase: "and"

Phrase: "resources."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035201:Resources [Idea or Concept]
Processing 00000000.tx.223: Given the value of the profiling information to cell biology and biochemistry, a strong argument for a national effort to completely define the composition of cellular and subcellular proteomes can be made.  

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the value of the profiling information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "to cell biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "a strong argument for a national effort"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0680226:argument [Social Behavior]
   748   C1704769:Argument [Conceptual Entity]

Phrase: "to completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "define"

Phrase: "the composition of cellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0486616:Composition [Clinical Attribute]
   770   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "subcellular proteomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0751973:Proteomes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.224: ACKNOWLEDGMENTS  This study was supported by National Institutes of Health Grants CA-69306 and HL-58925 (to J. W. Smith) and by Cancer Center Support Grant CA-30199.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grants CA-69306"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   818   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   742   C0018173:Grants [Quantitative Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0021622:Institutes [Organization]
   742   C1521721:Supported [Conceptual Entity]
   742   C3245503:national [Intellectual Product]
   708 E C0183683:Support [Medical Device]
   708 E C1272753:Institute [Idea or Concept]
   708 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "HL-58925"

Phrase: "("

Phrase: "to J. W. Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "and by Cancer Center Support Grant CA-30199."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1516176:Cancer Center Support Grant [Governmental or Regulatory Activity]
   770   C1513817:Cancer Center [Health Care Related Organization]
   767   C0006826:CA - Cancer [Neoplastic Process]
           Cancer
   744   C0018173:Grant [Quantitative Concept]
   744   C0183683:Support [Medical Device]
   744   C0205099:Center [Spatial Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1306459:Cancer [Finding]
   744   C1515981:And [Idea or Concept]
   744   C1521721:Support [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
Processing 00000000.tx.225: FOOTNOTES  Article published online before print. 

Phrase: "FOOTNOTES  Article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706852:Article [Intellectual Product]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "online before print."
Processing 00000000.tx.226: See web site for date of publication (http://physiolgenomics.physiology.org). 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "web site for date of publication"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2349146:Web Site [Intellectual Product]
   783   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0282111:Web [Manufactured Object]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//physiolgenomics.physiology.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.227: Address for reprint requests and other correspondence: J. 

Phrase: "Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376649:Address [Intellectual Product]
   770   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "J."
Processing 00000000.tx.228: W. 

Phrase: "W."
Processing 00000000.tx.229: Smith, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037 (E-mail: jsmith{at}burnham.org ).  

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "The Burnham Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "10901 North Torrey Pines Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442650:Road [Manufactured Object]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92037"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "jsmith{at}burnham.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.230: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Asano K, Vornlocher HP, Richter-Cook NJ, Merrick WC, Hinnebusch AG, and Hershey JW. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Asano K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Vornlocher HP,"

Phrase: "Richter-Cook NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027971:NJ [Geographic Area]

Phrase: "Merrick WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hinnebusch AG,"

Phrase: "and"

Phrase: "Hershey JW."
Processing 00000000.tx.231: Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. 

Phrase: "Structure of cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:Structure [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human eukaryotic initiation factor 3 subunits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1711351:Subunit [Quantitative Concept]
   734   C0752615:Eukaryotic Initiation Factor-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.232: Possible roles in RNA binding and macromolecular assembly. 

Phrase: "Possible roles in RNA binding"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "macromolecular assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.233: J Biol Chem 272: 2704227052, 1997.[Abstract/Free FullText] Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M, Sanchez JC, Frutiger S, Hughes G, Pallini V, Hochstrasser DF, and Tosi P. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2704227052,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bini L,"

Phrase: "Magi B,"

Phrase: "Marzocchi B,"

Phrase: "Arcuri F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tripodi S,"

Phrase: "Cintorino M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sanchez JC,"

Phrase: "Frutiger S,"

Phrase: "Hughes G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pallini V,"

Phrase: "Hochstrasser DF,"

Phrase: "and"

Phrase: "Tosi P."
Processing 00000000.tx.234: Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. 

Phrase: "Protein expression profiles in human breast ductal carcinoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C3463810:protein expression profile [Laboratory or Test Result]
   711   C1979963:Profile [Laboratory Procedure]
   711   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "histologically normal tissue."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040300:Normal Tissue [Tissue]
           Tissue
   901   C0332441:Normal tissue [Finding]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.235: Electrophoresis 18: 28322841, 1997.[ISI][Medline] Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, and Godwin AK. 

Phrase: "Electrophoresis 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: ":"

Phrase: "28322841,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bruening W,"

Phrase: "Giasson BI,"

Phrase: "Klein-Szanto AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Lee VM,"

Phrase: "Trojanowski JQ,"

Phrase: "and"

Phrase: "Godwin AK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]
Processing 00000000.tx.236: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. 

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed in the majority of breast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006141:Breast [Body Part, Organ, or Organ Component]
   753   C0680220:majority [Social Behavior]
   753   C1268990:Breast [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ovarian carcinomas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0029925:ovarian carcinomas [Neoplastic Process]
   966 E C0677886:carcinoma, ovarian [Neoplastic Process]
   861   C0007097:Carcinomas [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]

Phrase: "and in preneoplastic lesions of the ovary."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   793   C0567254:Lesion of ovary [Finding]
           lesions ovary
   748   C0029939:Ovary [Body Part, Organ, or Organ Component]
   748   C0221198:lesions [Finding]
   748   C0227898:ovary [Body Part, Organ, or Organ Component]
   748   C1278992:Ovary [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]
   714 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.237: Cancer 88: 21542163, 2000.[ISI][Medline] Chaney LK and Jacobson BS. 

Phrase: "Cancer 88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: ":"

Phrase: "21542163,"

Phrase: "2000."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chaney LK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038088:LK [Geographic Area]
   861   C2681928:LK [Gene or Genome]

Phrase: "and"

Phrase: "Jacobson BS."
Processing 00000000.tx.238: Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. 

Phrase: "Coating cells with colloidal silica"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0061622:Cell Coat [Cell Component]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "for high yield isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0204727:Isolation [Therapeutic or Preventive Procedure]
   827   C0205409:Isolation [Functional Concept]
   827   C0220862:isolation [Laboratory Procedure]
   755 E C1548221:Isolated [Idea or Concept]

Phrase: "of plasma membrane sheets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0439643:Sheets [Spatial Concept]
   793 E C2349187:Sheet [Quantitative Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "and"

Phrase: "identification of transmembrane proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.239: J Biol Chem 258: 10062100672, 1983.[Abstract/Free FullText] Clayton DF and George JM. 

Phrase: "J Biol Chem 258"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "10062100672,"

Phrase: "1983."

Phrase: "[Abstract/Free FullText"

Phrase: "] Clayton DF"

Phrase: "and"

Phrase: "George JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.240: The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. 

Phrase: "The synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a family of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "involved in synaptic function,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1314939:Involved [Functional Concept]
   770   C1705273:Function [Intellectual Product]

Phrase: "plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678558:Plasticity [Natural Phenomenon or Process]
   928 E C0032167:Plastic [Substance]

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.241: Trends Neurosci 21: 249254, 1998.[ISI][Medline] De Benedetti A and Harris AL. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 21"

Phrase: ":"

Phrase: "249254,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Benedetti A"

Phrase: "and"

Phrase: "Harris AL."
Processing 00000000.tx.242: eIF4E expression in tumors: its possible role in progression of malignancies. 

Phrase: "eIF4E expression in tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "its possible role in progression of malignancies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.243: Int J Biochem Cell Biol 31: 5972, 1999.[ISI][Medline] Donze O, Jagus R, Koromilas AE, Hershey JW, and Sonenberg N. 

Phrase: "Int J Biochem Cell Biol 31"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0007634:Cell [Cell]
   799   C0063789:INT [Organic Chemical]
   799   C0450355:31 [Intellectual Product]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "5972,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Donze O,"

Phrase: "Jagus R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Koromilas AE,"

Phrase: "Hershey JW,"

Phrase: "and"

Phrase: "Sonenberg N."
Processing 00000000.tx.244: Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. 

Phrase: "Abrogation of translation initiation factor eIF-2 phosphorylation"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "malignant transformation of NIH 3T3 cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0040682:cell transformation [Cell Function]
           Transformation
   767   C1510411:Cell Transformation [Pathologic Function]
           Transformation
   753   C1705163:Transformation [Research Activity]
Processing 00000000.tx.245: EMBO J 14: 38283834, 1995.[Abstract] Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, and Quinn TP. 

Phrase: "EMBO J 14"

Phrase: ":"

Phrase: "38283834,"

Phrase: "1995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Glinsky VV,"

Phrase: "Huflejt"

Phrase: "ME,"

Phrase: "Glinsky GV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376406:gv [Virus]

Phrase: "Deutscher SL,"

Phrase: "and"

Phrase: "Quinn TP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]
Processing 00000000.tx.246: Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on -galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. 

Phrase: "Effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of Thomsen-Friedenreich antigen-specific peptide P-30 on -galactoside-mediated homotypic aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   787   C0332621:Aggregation [Functional Concept]
   787   C0439168:% aggregation [Quantitative Concept]
   716 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "adhesion to the endothelium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "of MDA-MB-435 human breast carcinoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   845   C0427861:Human cells [Laboratory or Test Result]
   801   C1518174:Carcinoma Cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.247: Cancer Res 60: 25842588, 2000.[Abstract/Free FullText] Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R. 

Phrase: "Cancer Res 60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "25842588,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gygi SP,"

Phrase: "Rist B,"

Phrase: "Gerber SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Turecek F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Gelb MH,"

Phrase: "and"

Phrase: "Aebersold R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.248: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. 

Phrase: "Quantitative analysis of complex protein mixtures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1514534:Protein Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "isotope-coded affinity tags."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   812   C0022262:Isotope [Element, Ion, or Isotope]
   812   C1139855:tags [Medical Device]
   812   C1510827:Affinity [Natural Phenomenon or Process]
   779   C0009219:code [Occupational Activity]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779   C0805701:Code [Intellectual Product]
   779 E C1710492:TAG [Gene or Genome]
Processing 00000000.tx.249: Nat Biotechnol 17: 994999, 1999.[ISI][Medline] Jacobson BS, Stolz DB, and Schnitzer JE. 

Phrase: "Nat Biotechnol 17"

Phrase: ":"

Phrase: "994999,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jacobson BS,"

Phrase: "Stolz DB,"

Phrase: "and"

Phrase: "Schnitzer JE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]
Processing 00000000.tx.250: Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease. 

Phrase: "Identification of endothelial cell-surface proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "as targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521840:Target [Functional Concept]
   966   C2986546:TARGET [Diagnostic Procedure]

Phrase: "for diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "treatment of disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.251: Nat Med 2: 482484, 1996.[ISI][Medline] Jia T, Liu YE, Liu J, and Shi YE. 

Phrase: "Nat Med 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0796518:NAT-2 [Gene or Genome]
   913   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1705514:NAT-2 [Gene or Genome]

Phrase: ":"

Phrase: "482484,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jia T,"

Phrase: "Liu YE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]

Phrase: "Liu J,"

Phrase: "and"

Phrase: "Shi YE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]
Processing 00000000.tx.252: Stimulation of breast cancer invasion and metastasis by synuclein . Cancer Res 59: 742747, 1999.[Abstract/Free FullText] Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, and Hendrix MJ. 

Phrase: "Stimulation of breast cancer invasion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0404330:Breast stimulation [Therapeutic or Preventive Procedure]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "metastasis by synuclein . Cancer Res 59"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0027627:Metastasis [Neoplastic Process]
           metastatic cancer
   753   C2939420:metastasis [Neoplastic Process]
           metastatic cancer
   748   C0346957:metastatic cancer [Neoplastic Process]
   748   C2939419:Metastatic cancer [Neoplastic Process]

Phrase: ":"

Phrase: "742747,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kirschmann DA,"

Phrase: "Seftor EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Nieva DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Mariano EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "and"

Phrase: "Hendrix MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.253: Differentially expressed genes associated with the metastatic phenotype in breast cancer. 

Phrase: "Differentially expressed genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "associated with the metastatic phenotype in breast cancer."
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   793   C0278488:metastatic breast cancer [Neoplastic Process]
   770   C0006142:Breast Cancer [Neoplastic Process]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0678222:Breast Cancer [Neoplastic Process]
   767   C0027627:metastatic cancer [Neoplastic Process]
   767   C0346957:metastatic cancer [Neoplastic Process]
   767   C2939419:Metastatic cancer [Neoplastic Process]
   767   C2939420:metastatic cancer [Neoplastic Process]
   744   C0006141:Breast [Body Part, Organ, or Organ Component]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0031437:Phenotype [Organism Attribute]
   744   C0036525:Metastatic [Functional Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1268990:Breast [Body Part, Organ, or Organ Component]
   744   C1285572:Phenotype [Laboratory Procedure]
   744   C1306459:Cancer [Finding]
   744   C1522484:metastatic [Quantitative Concept]
   720 E C0153661:thoracic cancer [Neoplastic Process]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.254: Breast Cancer Res Treat 55: 127136, 1999.[ISI][Medline] Landry F, Lombardo CR, and Smith JW. 

Phrase: "Breast Cancer Res"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2347379:RES [Finding]
   734   C0006142:Breast Cancer [Neoplastic Process]
   734   C0678222:Breast Cancer [Neoplastic Process]

Phrase: "Treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "127136,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Landry F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lombardo CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "and"

Phrase: "Smith JW."
Processing 00000000.tx.255: A method for application of samples to matrix-assisted laser desorption ionization time-of-flight targets that enhances peptide detection. 

Phrase: "A method for application of samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "to matrix-assisted laser desorption ionization time-of-flight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C2348791:Time-of-Flight [Quantitative Concept]
   793   C1555977:Flight [Intellectual Product]
   793   C2610507:flight [Phenomenon or Process]
   723   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "that"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "peptide detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.256: Anal Biochem 279: 18, 2000.[ISI][Medline] Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, and Yates JR III. 

Phrase: "Anal Biochem 279"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "18,"

Phrase: "2000."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230613:AJ [Cell Component]

Phrase: "Eng J,"

Phrase: "Schieltz DM,"

Phrase: "Carmack E,"

Phrase: "Mize GJ,"

Phrase: "Morris DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Garvik BM,"

Phrase: "and"

Phrase: "Yates JR III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]
Processing 00000000.tx.257: Direct analysis of protein complexes using mass spectrometry. 

Phrase: "Direct analysis of protein complexes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.258: Nat Biotechnol 17: 676682, 1999.[ISI][Medline] Mann M. 

Phrase: "Nat Biotechnol 17"

Phrase: ":"

Phrase: "676682,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mann M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.259: A shortcut to interesting human genes: peptide sequence tags, expressed-sequence tags and computers. 

Phrase: "A shortcut to interesting human genes"

Phrase: ":"

Phrase: "peptide sequence tags,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0920679:peptide sequence [Amino Acid Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "expressed-sequence tags"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0600510:Expressed Sequence Tags [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "computers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009622:Computers [Manufactured Object]
Processing 00000000.tx.260: Trends Biochem Sci 21: 494495, 1996.[ISI][Medline] Mann M and Wilm M. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci 21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "494495,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mann M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Wilm M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: Error-tolerant identification of peptides in sequence databases by peptide sequence tags. 

Phrase: "Error-tolerant identification of peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in sequence databases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0242356:Databases [Intellectual Product]
   827 E C0993637:Database [Intellectual Product]

Phrase: "by peptide sequence tags."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0920679:peptide sequence [Amino Acid Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.262: Anal Chem 66: 43904399, 1994.[ISI][Medline] Nathan CA, Carter P, Liu L, Li BD, Abreo F, Tudor A, Zimmer SG, and De Benedetti A. 

Phrase: "Anal Chem 66"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C0201682:CHEM [Laboratory Procedure]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "43904399,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nathan CA,"

Phrase: "Carter P,"

Phrase: "Liu L,"

Phrase: "Li BD,"

Phrase: "Abreo F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tudor A,"

Phrase: "Zimmer SG,"

Phrase: "and"

Phrase: "De Benedetti A."
Processing 00000000.tx.263: Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. 

Phrase: "Elevated expression of eIF4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "FGF-2 isoforms during vascularization of breast carcinomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.264: Oncogene 15: 10871094, 1997.[ISI][Medline] Nicolson GL. 

Phrase: "Oncogene 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: ":"

Phrase: "10871094,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nicolson GL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]
Processing 00000000.tx.265: Trans-membrane control of the receptors on normal and tumor cells. 

Phrase: "Trans-membrane control of the receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "on normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "tumor cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: II. 

Phrase: "II."
Processing 00000000.tx.267: Surface changes associated with transformation and malignancy. 

Phrase: "Surface changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "associated with transformation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0040682:Transformation [Cell Function]
   790   C1510411:Transformation [Pathologic Function]
   790   C1705163:Transformation [Research Activity]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "malignancy."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0006826:Malignancy [Neoplastic Process]
  1000   C1306459:Malignancy [Finding]
   928 E C0205282:Malignant [Qualitative Concept]
   928 E C0334590:MALIGNANT [Neoplastic Process]
   928 E C1533592:MALIGNANT [Neoplastic Process]
Processing 00000000.tx.268: Biochim Biophys Acta 458: 172, 1976.[ISI][Medline] Nordling CO. 

Phrase: "Biochim Biophys Acta 458"

Phrase: ":"

Phrase: "172,"

Phrase: "1976."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nordling CO."
Processing 00000000.tx.269: A new theory on cancer-inducing mechanism. 

Phrase: "A new theory on cancer-inducing mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0871935:Theory [Idea or Concept]
Processing 00000000.tx.270: Br J Cancer 7: 6872, 1953.[ISI] Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, Borg A, Isola J, and Visakorpi T. 

Phrase: "Br J Cancer 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "6872,"

Phrase: "1953."

Phrase: "[ISI] Nupponen NN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1850406:NN [Disease or Syndrome]

Phrase: "Porkka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kakkola L,"

Phrase: "Tanner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Persson K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Borg A,"

Phrase: "Isola J,"

Phrase: "and"

Phrase: "Visakorpi T."
Processing 00000000.tx.271: Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. 

Phrase: "Amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "overexpression of p40 subunit of eukaryotic translation initiation factor 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514559:Overexpression [Genetic Function]

Phrase: "in breast"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "prostate cancer."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.272: Am J Pathol 154: 17771783, 1999.[Abstract/Free FullText] Pain VM. 

Phrase: "Am"

Phrase: "J Pathol 154"

Phrase: ":"

Phrase: "17771783,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pain VM."
Processing 00000000.tx.273: Initiation of protein synthesis in eukaryotic cells. 

Phrase: "Initiation of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1157563:protein synthesis initiation [Genetic Function]
   770   C0589507:Initiation [Mental Process]
   770   C1158830:Initiation [Genetic Function]
   770   C1704686:Initiation [Functional Concept]

Phrase: "in eukaryotic cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0015161:Eukaryotic Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.274: Eur J Biochem 236: 747771, 1996.[Abstract] Pasquali C, Fialka I, and Huber LA. 

Phrase: "Eur J Biochem 236"

Phrase: ":"

Phrase: "747771,"

Phrase: "1996."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pasquali C,"

Phrase: "Fialka I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Huber LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.275: Preparative two-dimensional gel electrophoresis of membrane proteins. 

Phrase: "Preparative two-dimensional gel electrophoresis of membrane proteins."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   793   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   770   C1705052:2-Dimensional [Spatial Concept]
   767   C0201719:electrophoresis proteins [Laboratory Procedure]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0205448:Two [Quantitative Concept]
   744   C1382104:Gel [Substance]
Processing 00000000.tx.276: Electrophoresis 18: 25732581, 1997.[ISI][Medline] Perillo NL, Marcus ME, and Baum LG. 

Phrase: "Electrophoresis 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: ":"

Phrase: "25732581,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perillo NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "Marcus"

Phrase: "ME,"

Phrase: "and"

Phrase: "Baum LG."
Processing 00000000.tx.277: Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. 

Phrase: "Galectins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0607430:Galectins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "versatile modulators of cell adhesion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1709060:Modulator [Manufactured Object]

Phrase: "cell proliferation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: J Mol Med 76: 402412, 1998.[ISI][Medline] Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dura A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, and Nussbaum RL. 

Phrase: "J Mol Med 76"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "402412,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polymeropoulos MH,"

Phrase: "Lavedan C,"

Phrase: "Leroy E,"

Phrase: "Ide SE,"

Phrase: "Dehejia A,"

Phrase: "Dura A,"

Phrase: "Pike B,"

Phrase: "Root H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein J,"

Phrase: "Boyer R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos ES,"

Phrase: "Chandrasekharappa S,"

Phrase: "Athanassiadou A,"

Phrase: "Papapetropoulos T,"

Phrase: "Johnson WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "Lazzarini"

Phrase: "AM"

Phrase: ","

Phrase: "Duvoisin RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Di Iorio G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Golbe LI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Nussbaum RL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]
Processing 00000000.tx.279: Mutation in the -synuclein gene identified in families with Parkinsons disease. 

Phrase: "Mutation in the -synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinsons disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.280: Science 276: 20452047, 1997.[Abstract/Free FullText] Price JE, Polyzos A, Zhang RD, and Daniels LM. 

Phrase: "Science 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "20452047,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Price JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Polyzos A,"

Phrase: "Zhang RD,"

Phrase: "and"

Phrase: "Daniels LM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]
Processing 00000000.tx.281: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. 

Phrase: "Tumorigenicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519697:Tumorigenicity [Pathologic Function]

Phrase: "and"

Phrase: "metastasis of human breast carcinoma cell lines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0346993:Breast Metastasis [Neoplastic Process]
   769   C0278488:Metastatic Breast Carcinoma [Neoplastic Process]
   748   C0027627:Metastasis [Neoplastic Process]
   748   C2939420:metastasis [Neoplastic Process]
   738   C1384494:Metastatic Carcinoma [Neoplastic Process]

Phrase: "in nude mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025932:Mice, Nude [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C1425014:NUDE [Gene or Genome]
Processing 00000000.tx.282: Cancer Res 50: 717721, 1990.[Abstract] Rabilloud T, Adessi C, Giraudel A, and Lunardi J. 

Phrase: "Cancer Res 50"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "717721,"

Phrase: "1990."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rabilloud T,"

Phrase: "Adessi C,"

Phrase: "Giraudel A,"

Phrase: "and"

Phrase: "Lunardi J."
Processing 00000000.tx.283: Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. 

Phrase: "Improvement of the solubilization of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986411:Improvement [Conceptual Entity]

Phrase: "in two-dimensional electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   901   C1705052:2-Dimensional [Spatial Concept]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0205448:Two [Quantitative Concept]
   755   C0439534:Dimension [Quantitative Concept]
   755   C1707753:Dimensionality [Spatial Concept]

Phrase: "with immobilized pH gradients."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C1138565:pH gradient [Quantitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]
Processing 00000000.tx.284: Electrophoresis 18: 307316, 1997.[ISI][Medline] Raught B, Gingras AC, James A, Medina D, Sonenberg N, and Rosen JM. 

Phrase: "Electrophoresis 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: ":"

Phrase: "307316,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Raught B,"

Phrase: "Gingras AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "James A,"

Phrase: "Medina D,"

Phrase: "Sonenberg N,"

Phrase: "and"

Phrase: "Rosen JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.285: Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein  isoform and up-regulation of the eukaryotic translation initiation factor 2 are correlated with neoplastic transformation of mammary epithelial cells. 

Phrase: "Expression of a translationally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "dominant-negative CCAAT/enhancer-binding protein  isoform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform
   710   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "up-regulation of the eukaryotic translation initiation factor 2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C1157536:up-regulation of translational initiation [Cell Function,Genetic Function]
   789   C1157543:regulation of translational initiation [Cell Function]
   784   C1157519:regulation of translation [Cell Function]
   764   C0041904:Up-Regulation [Cell Function,Molecular Function]
   764   C0162493:Up-Regulation [Genetic Function]
   742   C0547043:Up [Spatial Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1282911:Up [Spatial Concept]
   742   C1327622:Regulation [Biologic Function]
   726   C3537096:Translational Regulation [Genetic Function]

Phrase: "are"

Phrase: "correlated with neoplastic transformation of mammary epithelial cells."
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   778   C0007621:Cell Transformation, Neoplastic [Neoplastic Process]
           neoplastic transformation
   776   C1513959:Neoplastic Epithelial Cell [Cell]
   770   C0014597:Epithelial Cells [Cell]
   770   C1273342:Epithelial Cells [Laboratory Procedure]
   767   C0597032:Neoplastic cells [Cell]
   750   C0040682:cell transformation [Cell Function]
           Transformation
   750   C1510411:Cell Transformation [Pathologic Function]
           Transformation
   744   C0006141:Mammary [Body Part, Organ, or Organ Component]
   744   C0007634:Cells [Cell]
   744   C0221908:Epithelial [Qualitative Concept]
   744   C0929301:Mammary [Body Part, Organ, or Organ Component]
   744   C1705163:Transformation [Research Activity]
   744   C1707520:Correlated [Qualitative Concept]
   744   C1709160:Neoplastic [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.286: Cancer Res 56: 43824386, 1996.[Abstract] Shevchenko A, Wilm M, Vorm O, and Mann M. 

Phrase: "Cancer Res 56"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "43824386,"

Phrase: "1996."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shevchenko A,"

Phrase: "Wilm M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vorm O,"

Phrase: "and"

Phrase: "Mann M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. 

Phrase: "Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C0002518:protein sequencing [Amino Acid Sequence]
   745   C0751971:Protein Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   742   C1553778:Sequencing [Intellectual Product]
   742   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.288: Anal Chem 68: 850858, 1996.[ISI][Medline] Stinson SF, Alley MC, Kopp WC, Fiebig HH, Mullendore LA, Pittman AF, Kenney S, Keller J, and Boyd MR. 

Phrase: "Anal Chem 68"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C0201682:CHEM [Laboratory Procedure]
   827   C0450387:68 [Intellectual Product]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "850858,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stinson SF,"

Phrase: "Alley MC,"

Phrase: "Kopp WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Fiebig HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Mullendore LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Pittman AF,"

Phrase: "Kenney S,"

Phrase: "Keller J,"

Phrase: "and"

Phrase: "Boyd MR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]
Processing 00000000.tx.289: Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. 

Phrase: "Morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "immunocytochemical characteristics of human tumor cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0870672:Human Characteristics [Group Attribute]
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "for use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "in a disease-oriented anticancer drug screen."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0013207:Drug Screen, Anti-Cancer [Laboratory Procedure]
   840   C0038577:Drug Screen [Laboratory Procedure]
   840   C0373483:Drug Screen [Laboratory Procedure]
   804   C0220908:screen [Health Care Activity]
   804   C1305399:screen [Functional Concept]
   804   C1705053:Screen [Medical Device]
Processing 00000000.tx.290: Anticancer Res 12: 10351053, 1992.[ISI][Medline] Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DAC, Kondo J, Ihara Y, and Saitoh T. 

Phrase: "Anticancer Res 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "10351053,"

Phrase: "1992."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ueda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fukushima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Masliah E,"

Phrase: "Xia Y,"

Phrase: "Iwai A,"

Phrase: "Yoshimoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Otero DAC,"

Phrase: "Kondo J,"

Phrase: "Ihara Y,"

Phrase: "and"

Phrase: "Saitoh T."
Processing 00000000.tx.291: Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. 

Phrase: "Molecular cloning of cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "an unrecognized component of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.292: Proc Natl Acad Sci USA 90: 1128211286, 1993.[Abstract] Williams K, Chubb C, Huberman E, and Giometti CS. 

Phrase: "Proc Natl Acad Sci USA 90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439083:>90 [Quantitative Concept]
   799   C0439087:<90 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1128211286,"

Phrase: "1993."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Williams K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chubb C,"

Phrase: "Huberman E,"

Phrase: "and"

Phrase: "Giometti CS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]
Processing 00000000.tx.293: Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. 

Phrase: "Analysis of differential protein expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1882495:Protein Expression Analysis [Laboratory Procedure]
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "neoplastic human breast epithelial cell lines."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   885   C1513959:Neoplastic Epithelial Cell [Cell]
   876   C0597032:Neoplastic Cell [Cell]
   869   C0682523:Human Cell Line [Cell]
   858   C0427861:human cell [Laboratory or Test Result]
   827   C0007600:Cell lines [Cell]
   827   C0014597:Epithelial cell [Cell]
   813   C0230087:Mammary line [Body Location or Region]
   799   C0007634:Cell [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C0221908:Epithelial [Qualitative Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.294: Electrophoresis 19: 333343, 1998.[ISI][Medline] Wong NC, Mueller BM, Barbas CF, Ruminski P, Quaranta V, Lin EC, and Smith JW. 

Phrase: "Electrophoresis 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: ":"

Phrase: "333343,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wong NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Mueller BM,"

Phrase: "Barbas CF,"

Phrase: "Ruminski P,"

Phrase: "Quaranta V,"

Phrase: "Lin EC,"

Phrase: "and"

Phrase: "Smith JW."
Processing 00000000.tx.295: v Integrins mediate adhesion and migration of breast carcinoma cell lines. 

Phrase: "v Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "migration of breast carcinoma cell lines."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1622501:Migration, Cell [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.296: Clin Exp Metastasis 16: 5061, 1998.[ISI][Medline] Xu XC, el-Naggar AK, and Lotan R. 

Phrase: "Clin Exp Metastasis 16"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0027627:Metastasis [Neoplastic Process]
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]
   812   C2939420:metastasis [Neoplastic Process]
   741 E C0036525:Metastatic [Functional Concept]
   741 E C1522484:metastatic [Quantitative Concept]

Phrase: ":"

Phrase: "5061,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu XC,"

Phrase: "el-Naggar AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001905:AK [Geographic Area]
   827   C1412243:AK [Gene or Genome]

Phrase: "and"

Phrase: "Lotan R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.297: Differential expression of galectin-1 and galectin-3 in thyroid tumors. 

Phrase: "Differential expression of galectin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "galectin-3 in thyroid tumors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0245382:Galectin 3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C1416831:GALECTIN 3 [Gene or Genome]
   760   C0607430:Galectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.298: Potential diagnostic implications. 

Phrase: "Potential diagnostic implications."
Processing 00000000.tx.299: Am J Pathol 147: 815822, 1995.[Abstract] Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, and Kirino T. 

Phrase: "Am"

Phrase: "J Pathol 147"

Phrase: ":"

Phrase: "815822,"

Phrase: "1995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yamaoka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mishima K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nagashima Y,"

Phrase: "Asai A,"

Phrase: "Sanai Y,"

Phrase: "and"

Phrase: "Kirino T."
Processing 00000000.tx.300: Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. 

Phrase: "Expression of galectin-1 mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1515670:mRNA Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "correlates with the malignant potential of human gliomas"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   767   C0555198:Malignant Gliomas [Neoplastic Process]
       E   [M]Glioma NOS
   744   C0017638:[M]Gliomas [Neoplastic Process]
   744   C0086418:Human [Human]
   744   C0205282:Malignant [Qualitative Concept]
   744   C0334590:MALIGNANT [Neoplastic Process]
   744   C1533592:MALIGNANT [Neoplastic Process]
   744   C3245505:Potential [Qualitative Concept]
   711 E C2984291:Glioma [Functional Concept]

Phrase: "and"

Phrase: "expression of antisense galectin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the growth of 9 glioma cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   809   C0007595:growth of cell [Cell Function]
           cells growth
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
Processing 00000000.tx.301: J Neurosci Res 59: 722730, 2000.[ISI][Medline] Yim MB, Chae HZ, Rhee SG, Chock PB, and Stadtman ER. 

Phrase: "J Neurosci Res 59"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "722730,"

Phrase: "2000."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yim MB,"

Phrase: "Chae HZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439482:Hz [Quantitative Concept]

Phrase: "Rhee SG,"

Phrase: "Chock PB,"

Phrase: "and"

Phrase: "Stadtman ER."
Processing 00000000.tx.302: On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. 

Phrase: "On the protective mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "of the thiol-specific antioxidant enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "against the oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "of biomacromolecules."
Processing 00000000.tx.303: J Biol Chem 269: 16211626, 1994.[Abstract/Free FullText]

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "16211626,"

Phrase: "1994."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

